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HSCs are quiescent under homeostatic conditions to retain their key functional features and maintain a stable pool1,2. Under certain stress conditions, such as chemotherapy, 
HSCs are activated, enter the cell cycle and differentiate to replen-
ish the haematopoietic system3. Interferon (IFN), G-CSF, IL-1 
signalling and pathogens have key roles in regulating HSC quies-
cence and activation4–7. However, how inflammation is activated in 
HSCs after a challenge is not fully understood. The innate immune 
receptor MDA5 belongs to the family of retinoic-acid-inducible 
gene I (RIG-I)-like receptors and, after its activation, induces 
inflammation by activating type-I interferons and proinflamma-
tory cytokines8. Thus, MDA5 could potentially have a role in HSC 
activation in response to stress. Nevertheless, the canonical trigger 
for MDA5 activation is viral RNA that should not exist in HSCs 
in non-infectious conditions. Thus, an endogenous ligand could 
activate MDA5 in HSCs. Recently, it has been established that 
TE transcripts and other endogenous ligands can bind to MDA5 
(refs. 8,9). For example, Alu (non-autonomous retrotransposon 
TE family) transcripts can bind to and activate MDA5 when the 
RNA-editing enzyme ADAR is absent10–12. Upregulation of TEs by 
demethylating drugs also activates MDA5 (refs. 13,14). Depending 
on their transposition mechanisms, TEs can be classified into DNA 
transposons or retrotransposons that can be further separated into 
long terminal repeat elements (LTRs), such as endogenous retro-
viruses, or non-LTR elements, such as long interspersed nuclear 
elements (LINEs) and short interspersed nuclear elements (SINEs). 
Each of these subclasses contains several TE superfamilies that con-
sist of numerous TE families that harbour tens to thousands of cop-
ies15. TEs are not only a source of mutation16 through transposition, 
but are also activated by various stress signals17–19. In the haema-
topoietic system, ageing and irradiation lead to the expression of 
diverse TE families in HSCs20,21. TE transcripts present during stress 
could therefore activate MDA5 to induce inflammatory signalling 
that is necessary for HSCs to exit quiescence.
In this Article, we show that, during haematopoietic regeneration 
after chemotherapy, increased expression of TEs induces activation 
Chemotherapy-induced transposable elements 
activate MDA5 to enhance haematopoietic 
regeneration
Thomas Clapes   1,14, Aikaterini Polyzou1,2,14, Pia Prater1,2,3,14, Sagar4,5, Antonio Morales-Hernández6,  
Mariana Galvao Ferrarini   7, Natalie Kehrer   1,2, Stylianos Lefkopoulos   1,2,3, Veronica Bergo1,2,3,  
Barbara Hummel4, Nadine Obier1, Daniel Maticzka8, Anne Bridgeman9, Josip S. Herman   4,10,  
Ibrahim Ilik11, Lhéanna Klaeylé1, Jan Rehwinkel   9, Shannon McKinney-Freeman   6, Rolf Backofen   8,12, 
Asifa Akhtar   11,12, Nina Cabezas-Wallscheid   1,12, Ritwick Sawarkar4,12,13, Rita Rebollo7, 
Dominic Grün   4,10,12 and Eirini Trompouki   1,12 ✉
Haematopoietic stem cells (HSCs) are normally quiescent, but have evolved mechanisms to respond to stress. Here, we 
evaluate haematopoietic regeneration induced by chemotherapy. We detect robust chromatin reorganization followed by 
increased transcription of transposable elements (TEs) during early recovery. TE transcripts bind to and activate the innate 
immune receptor melanoma differentiation-associated protein 5 (MDA5) that generates an inflammatory response that is 
necessary for HSCs to exit quiescence. HSCs that lack MDA5 exhibit an impaired inflammatory response after chemotherapy 
and retain their quiescence, with consequent better long-term repopulation capacity. We show that the overexpression of 
ERV and LINE superfamily TE copies in wild-type HSCs, but not in Mda5−/− HSCs, results in their cycling. By contrast, after 
knockdown of LINE1 family copies, HSCs retain their quiescence. Our results show that TE transcripts act as ligands that 
activate MDA5 during haematopoietic regeneration, thereby enabling HSCs to mount an inflammatory response necessary 
for their exit from quiescence.
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of the innate immune receptor MDA5. Subsequently, MDA5 signal-
ling leads to an inflammatory response that is crucial for HSCs to 
exit quiescence and proliferate.
Results
Inflammatory signalling is activated in HSCs following che-
motherapy. To understand the molecular mechanisms that gov-
ern haematopoietic regeneration, we performed RNA-sequencing 
(RNA-seq) analysis of HSCs from C57Bl/6J wild-type (WT) mice 
treated with the myeloablative agent 5-fluoruracil (5-FU). This 
treatment eliminates all cycling cells and forces HSCs to exit quies-
cence and proliferate to replenish the bone marrow (BM) cells22,23. 
We sorted HSCs (lineage−Sca-1+c-Kit+CD48−CD150+, also known 
as LSK/SLAM, referred to as HSCs in this manuscript) at homeo-
static conditions (day 0 (D0)), as well as at 2 h, 6 h and 16 h (H2, 
H6 and H16, respectively), 3 d (D3, proliferation start23) and 10 d 
(D10) after 5-FU injection (Extended Data Fig. 1a,b). Sorting 
EPCR/SLAM HSCs23 to avoid the change in c-kit expression after 
chemotherapy showed that more than 90% of EPCR/SLAM cells 
fall within the LSK/SLAM gate at D0, H2 and H6 and more than 
80% at H16 (Extended Data Fig. 1c). The percentage of EPCR− cells 
in the LSK/SLAM gating was similar from D0 to H16 (Extended 
Data Fig. 1d).
We analysed the transcriptional response during the 5-FU chal-
lenge by comparing the RNA-seq data between D0 and all of the 
consecutive time points. Few deregulated genes were observed at 
H2, but they increase throughout the time course and many genes 
remain deregulated even at D10 after treatment (51 (H2), 1,443 
(H16), 1,319 (D10) deregulated genes; fold change cut-off = 1.5; 
Padj < 0.05; Fig. 1a and Supplementary Tables 1–5). Gene ontology 
(GO) analysis showed that ‘inflammatory response’ was enriched in 
upregulated genes from H2 to D10 (Extended Data Fig. 1e). Given 
the important role of inflammatory signalling in HSCs4,5,24, we iden-
tified the interferon-regulated genes (IRGs) from the Interferome 
database (http://interferome.org)25 and found upregulation of 
IRGs, especially at H16 and a second wave at D10 (Fig. 1b). We 
also sequenced 480 WT single HSCs from D0 and 997 from H16 
(Fig. 1c). Gene set enrichment analysis (GSEA) showed enrich-
ment for Toll-like receptor and cytokine signalling at H16 (Fig. 1d). 
The HSC marker Procr (also known as Epcr) was highly expressed 
in D0 HSCs, while the activation marker Cdk6 and IRGs such as 
Ifitm2 and Ifitm3 were highly expressed in HSCs at H16 (Fig. 1e,f 
and Supplementary Table 6). Collectively, our results at the bulk and 
single-cell level show that inflammation-related genes are activated 
after chemotherapy.
Chemotherapy leads to chromatin reorganization in HSCs. To 
examine changes in chromatin accessibility during chemotherapy, 
we performed an assay for transposase-accessible chromatin fol-
lowed by sequencing (ATAC-seq) at the same time points after 
chemotherapy. By comparing the early timepoints H2, H6 and H16 
with D0, we found ~6,000 common accessible regions, mostly span-
ning transcriptional start sites (TSS), and ~13,000 regions gain-
ing accessibility and spanning TSS, introns and intergenic regions 
(Fig. 1g and Supplementary Tables 7–11). Some regions also lost 
accessibility. By comparing H16, D3 and D10 with D0, we found 
~4,000 regions that are uniquely accessible at H16 and lose acces-
sibility by D3 (Fig. 1h). We assigned the differential ATAC-seq 
peaks to genes (−100 kb/+25 kb from the TSS) and identified a sig-
nificant overlap, with the differentially expressed genes at all of the 
time points except for H2 showing enrichment for inflammatory 
response genes (Extended Data Fig. 1f,g). By performing digital 
footprinting analysis to identify motif occupancy for transcription 
factors, we observed increased occupancy for IRF3, NF-κB (p65) 
and STAT1 at H2, which peaked at H16 and was less prominent at 
D3 after chemotherapy (Fig. 1i). Our genome-wide analysis shows 
that, after myeloablative stress, changes in chromatin accessibility 
are observed in HSCs.
TE family expression is increased during haematopoietic regener-
ation. We next wondered whether chromatin reorganization affects 
the expression of the repetitive part of the genome and investigated 
the expression of TE families by mapping the RNA-seq reads using 
STAR26, and quantifying TE family expression using TEtranscripts27 
(multi-mapped reads). Upregulation of TE families was observed. 
Indeed, the RLTR41:ERV1:LTR family is already upregulated at H2, 
whereas 5 and 12 families are upregulated at H6 and H16, respec-
tively (fold change cut-off = 1.5; Padj < 0.05). This increase in expres-
sion is progressive as the families upregulated at H2 and H6 remain 
upregulated at H16 (Fig. 2a,b and Supplementary Table 12). At D10, 
nine families are upregulated in total and six of them are new, con-
comitant to a second wave of IRGs. Downregulation of two families 
occurs at D3 and D10 (Fig. 2a,b). The majority of deregulated TEs 
belong to the LINE1, ERV1 and ERVK families (Fig. 2a). We next 
intersected the uniquely mapped ATAC-seq peaks (Supplementary 
Table 13) with TE copies (±1 kb to increase mapping). We searched 
for TE families that were enriched in ATAC-seq, but also deregu-
lated after 5-FU treatment to pinpoint specific families suffering 
chromatin changes and consequent transcriptional activation. Only 
one upregulated TE family, MMVL30-int:ERV1:LTR, was enriched 
in newly accessible chromatin regions (Fig. 2a). Upregulated TE 
families were also identified at the single-cell level, albeit differences 
were observed between bulk and single-cell RNA-seq (Fig. 2c–e and 
Supplementary Table 14). These results confirm that TE families are 
upregulated after chemotherapy.
We next examined whether deregulation of TE family expression 
is due to deregulation of several or specific copies within a family. 
We filtered for uniquely mapping RNA-seq reads and unravelled 
specific TE copies with expression changes after 5-FU treatment at 
H16, D3 and D10. This analysis should be taken with caution, as 
Fig. 1 | 5-Fu treatment results in the upregulation of inflammatory signalling in HSCs. a, The number of differentially expressed genes at different time 
points after 5-FU treatment in WT HSCs (LSK/SLAM). n = 2 (H2, H6 and D3) and n = 3 (D0, H16 and D10) biologically independent samples. Fold change 
cut-off = 1.5. Padj < 0.05. b, Heat map of the normalized fold change in the union of IRGs upregulated in WT HSCs at the indicated time points compared 
to D0. Fold change cut-off = 1.5. Padj < 0.05 in at least one time point. c, t-Distributed stochastic neighbour embedding (t-SNE) representation showing 
sorted WT HSCs at D0 in cyan and at H16 in green (the number of sequenced cells is shown in parentheses). d, GSEA of differentially expressed genes 
among D0 and H16 WT HSCs from c. NES, normalized enrichment score. e, The log2-transformed fold change in expression of the indicated genes at D0 
or H16 in WT HSCs from c. The boxes show the interquartile range, the whiskers show the minimum and maximum values, and the horizontal line shows 
the median value. Each dot represents a single cell and the shape of the plot represents probability density. n = 480 (WT D0) and n = 997 (H16) cells. One 
independent experiment per time point. Padj < 0.05. f, t-SNE representation showing the expression of differentially expressed genes among H16 and D0 
in WT HSCs. The colour scale represents the log2-transformed normalized transcript counts. g,h, Heat maps (left) of the differentially accessible regions 
in WT HSCs at the indicated early (g) and late (h) time points ±3 kb from the centre of the peak (CoP). Right, the genomic location distribution of the 
accessible regions. i, Average normalized Tn5 insertion profiles around footprinted motifs (p65, IRF3, STAT1) in merged ATAC peaks at the indicated time 
points after 5-FU treatment in WT HSCs. Footprint numbers (n) are indicated at the top. Footprint occupancy scores (FOS) indicate the significance versus 
D0. Insertions on the sense and antisense DNA strands are indicated in red and blue, respectively.
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many recent and potentially active TE copies will not be included 
due to mapping issues. We found that 37 TE copies were upregu-
lated at H16, 42 at D3 and 37 at D10, which also showed signifi-
cant downregulation of many TE copies (fold change cut-off 1.5; 
Padj < 0.05; Fig. 2f and Supplementary Table 15). We then examined 
whether the deregulated TE copies were proximal to deregulated 
genes17. We identified the genes proximal to upregulated TE cop-
ies (±30 kb from the gene TSS). As a control, we searched TE–gene 
pairs using a random list of genes. The percentages of deregulated 
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and the result was significant for H16 (Fig. 2g). Thus, few copies 
were confidently detected as upregulated after chemotherapy and 
some of these copies are proximal to deregulated genes.
TE transcripts could act as MDA5 ligands after stress. We next 
hypothesized that upregulated TE transcripts could activate the innate 
immune receptor MDA5 leading to the inflammatory signalling 
a
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Fig. 2 | Rapid TE upregulation in HSCs after 5-Fu treatment. a, Heat map of the log2-transformed fold change of differentially expressed TE families 
(DETEs) detected in WT HSCs at the indicated time points after 5-FU treatment. TE families that have a significantly enriched ATAC-seq peak nearby 
(±1 kb) are highlighted in the right column (A). b, The number of upregulated or downregulated TE families at the indicated time points after 5-FU 
treatment. c, t-SNE representation of sorted WT HSCs (LSK/SLAM) at D0 (green) and H16 (dark green) (the number of sequenced cells is shown in 
parentheses). d, t-SNE representation showing the expression of differentially expressed TE families between H16 and D0 in WT HSCs. The colour scale 
represents the log2-transformed normalized transcript counts. e, The log2-transformed fold change in expression of the TE families in d at D0 or H16 
in WT HSCs from c. The box shows the interquartile range, the whiskers show the minimum and maximum values, and the horizontal line shows the 
median value. Each dot represents a single cell and the shape of the plot represents probability density. n = 712 (WT D0) and n = 1,229 (H16) cells. One 
independent experiment per time point. Padj < 0.05. f, Heat map of the expression values (fold change) of TE copies in WT HSCs at the indicated time 
points compared to D0. Fold change cut-off = 1.5. Padj < 0.05. g, The overlap between genes in proximity (±30 kb from TSS of the genes) to upregulated TE 
copies in WT HSCs and deregulated genes at H16 (P < 8.25 × 10−4). The P value of the control overlap after gene shuffling is also shown (P < 0.068).
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observed during regeneration. To determine whether TE transcripts 
bind to MDA5 in response to stress, we performed fast ligation of 
RNA after some sort of affinity purification for high-throughput 
sequencing (FLASH)28 analysis in HEK293 human embryonic kid-
ney cells overexpressing green fluorescent protein (GFP) or MDA5. 
Irradiation was used as a stress signal and the methyltransferase 
inhibitor decitabine was used as a positive control29. We observed 
binding of MDA5 to RNA of SINEs, LINEs, LTRs, some DNA 
transposons and mitochondrial RNAs, consistent with previous rep
orts10,13,14,30 (Supplementary Tables 16 and 17). Overall, after irradia-
tion or decitabine treatment, binding of TE transcripts to MDA5 
was higher than binding to control GFP protein (Extended Data Fig. 
2a,c), or to MDA5 in the absence of any treatment (Extended Data 
Fig. 2b,c). Notably, some coding genes and other RNAs can bind 
to MDA5. These results were confirmed by qPCR after ultraviolet 
cross-linking for a panel of TEs in HEK293 cells, but also in mouse 
OP9 stromal cells (Extended Data Fig. 2d–f). These results show 
that TE transcripts could bind to MDA5 after stress.
Mda5−/− HSCs are resistant to activation and have a better 
repopulation capacity. We reasoned that, if MDA5 has a func-
tional role in HSC activation, ablation of MDA5 should have con-
sequences in HSC biology. We examined the function of MDA5 
in HSCs using Ifih1-knockout (also known as Mda5; hereafter 
Mda5−/−; B6.Cg-Ifih1tm1.1Cln/J)31. We analysed BM cellularity, the 
frequency and absolute numbers of HSCs, multipotent progeni-
tors (MPP1–4) and differentiated haematopoietic populations, and 
found no significant differences between the knockout and WT 
mice under homeostatic conditions (Fig. 3a–c). As Mda5 is an IRG, 
we confirmed that SCA-1 expression was not affected in Mda5−/− 
HSCs and that the frequency of HSCs in the BM using the side 
population32 remained unchanged (Extended Data Fig. 3a,b). Thus, 
MDA5 does not interfere with the haematopoietic composition of 
the BM under steady-state conditions.
To determine HSC clonogenic activity, we sorted HSCs from 
WT and Mda5−/− mice and performed colony-forming-unit-cell 
(CFU-C) replating assays. Mda5−/− HSCs produced more CFU-C 
colonies after the third and fourth plating compared with WT HSCs 
(Fig. 3d). Competitive in vivo transplantation assays showed no sig-
nificant differences in primary transplantations (Fig. 3e). Homing 
and contribution to myeloid and lymphoid lineages was similar 
between WT and Mda5−/− HSCs (Extended Data Fig. 3c,d). The 
levels of chimerism were higher in secondary recipients that were 
transplanted with Mda5−/− HSCs compared with in those that were 
injected with WT HSCs (Fig. 3e). However, after serial 5-FU injec-
tions every 10 d, the Mda5−/− mice died significantly earlier than 
WT mice (Fig. 3f). These results imply that Mda5−/− HSCs may 
be more quiescent compared with WT HSCs, therefore perform-
ing better in the long-term; however, during rapid acute stress such 
as serial 5-FU injections, Mda5−/− mice are not able to reconstitute 
their blood system fast enough.
Next, we examined the cell cycle status of Mda5−/− HSCs. When 
compared to the WT, the BM of Mda5−/− mice had significantly more 
quiescent (cells in G0) HSCs after treatment with 5-FU, but also at 
steady state (Fig. 3g and Extended Data Fig. 3e). This steady-state 
phenotype was also significant for MPP1 cells, but not for other 
progenitors (Extended Data Fig. 3e). Mda5−/− HSCs also had lower 
mitochondrial mass and reactive oxygen species (ROS) levels com-
pared with their WT counterpart at D0, but not at D3 (Fig. 3h and 
Extended Data Fig. 3f). By examining γH2AX foci as a biomarker 
for HSC activation, we detected fewer γH2AX foci in Mda5−/− HSCs 
compared with in WT HSCs at D3 after 5-FU injection or after cul-
ture, consistent with their ability to remain in G0 state (Extended 
Data Fig. 3g,h). Furthermore, the percentage of HSCs undergoing 
at least one division was decreased after 24 h and 48 h (although not 
significant in the latter) when cultured ex vivo (Fig. 3i). We also 
transplanted WT or Mda5−/− HSCs that remained in culture for 
48 h and observed that animals receiving Mda5−/− HSCs exhibited 
higher chimerism levels (Fig. 3j). Finally, we checked whether the 
lack of MDA5 impairs HSC activation after the use of other chemo-
therapeutics, namely cytarabine and cyclophosphamide. Cytarabine 
treatment, at least at the dose that we used, could not drive HSC 
cycling, but cyclophosphamide treatment led to HSC cycling and 
this function was impaired in Mda5−/− HSCs (Extended Data Fig. 
3i,j). Together these results suggest that HSCs lacking MDA5 exhibit 
impaired exit from quiescence during regenerative stress.
Chemotherapy induces TE transcription in Mda5−/− HSCs. We 
next reasoned that Mda5−/− HSCs retain their quiescence either 
because TEs are not upregulated or because the activation of 
inflammatory signalling is impaired in Mda5−/− mice. TE families 
were indeed deregulated in Mda5−/− HSCs; 4 families were upreg-
ulated at H2, 7 at H16 and 6 at D3, belonging mostly to LINE1, 
ERVK and ERV1 families (Fig. 4a and Supplementary Table 18). 
Five out of the seven upregulated families at H16 were also upregu-
lated for the WT. However, downregulation of TE families was also 
observed in Mda5−/− HSCs, especially at D3 (Fig. 4a). One fam-
ily, MMERGLN-int:ERV1:LTR, was enriched in newly accessible 
chromatin regions, but four of the downregulated families were 
enriched in regions that lost accessibility (Fig. 4a). At the single-cell 
level, TE families that were upregulated in the single-cell RNA-seq 
analysis of WT HSCs were also upregulated in Mda5−/− HSCs 
Fig. 3 | MDA5 is required for HSC activation. a, The BM cellularity of WT or Mda5−/− mice. n = 13 biologically independent samples. Data are mean + s.d. 
Statistical analysis was performed using two-tailed t-tests. b, The frequency (left) and the absolute numbers (right) of LT-HSCs, and MPPs from BM of 
WT or Mda5−/− mice. n = 6 (BM frequency) and n = 5 (absolute numbers) biologically independent samples. Data are mean + s.d. Statistical analysis 
was performed using two-tailed t-tests. c, The frequency of myeloid (My; CD11+Gr1+), erythroid (Ery; Ter119+), B cells (B220+) in the BM and T cells 
(CD3+) in the thymus. For myeloid, erythroid and B cells, n = 2 (WT) and n = 3 (Mda5−/−); and, for T cells, n = 6 biologically independent samples. 
Data are mean + s.d. Statistical analysis was performed using two-tailed t-tests. d, Serial CFU-C assay of BM HSCs from WT or Mda5−/− mice scored 
every 7 d. n = 3 biologically independent samples. Data are mean ± s.d. Statistical analysis was performed using two-tailed t-tests. e, The percentage of 
donor-derived cells in peripheral blood (PB) of primary and secondary recipients in weeks after injection. The dotted line separates the primary from 
secondary transplantation. n = 30 (primary) and n = 15 (secondary) biologically independent samples, with n = 4 and n = 3 independent experiments, 
respectively. Data are mean ± s.e.m. Statistical analysis was performed using two-tailed t-tests. f, Kaplan–Meier survival curve of WT or Mda5−/− mice 
after 5-FU injections every 10 d. n = 8 mice. Statistical analysis was performed using the log-rank (Mantel–Cox) test. g, Cell cycle status of WT or Mda5−/− 
HSCs after 5-FU treatment. For WT, n = 8 (D0), n = 5 (D4) and n = 4 (D10); and, for Mda5−/−, n = 9 (D0), n = 5 (D4) n = 6 (D10) biologically independent 
samples. Data are mean ± s.d. Statistical analysis was performed using two-tailed t-tests. h, The frequency of cells with detectable mitochondrial mass 
(left) and ROS (right) at D0. n = 4 biologically independent samples. Data are mean + s.d. Statistical analysis was performed using two-tailed t-tests. i, The 
percentage of HSCs (LSK/SLAM, Flk2+) that had undergone at least one division or no division after 24 h or 48 h. n = 3 biologically independent samples. 
Data are mean ± s.d. Statistical analysis was performed using two-tailed t-tests. j, The percentage of donor-derived cells in the peripheral blood of primary 
recipients transplanted with either WT or Mda5−/− HSCs cultured for 48 h. n = 5 biologically independent samples. Data are mean ± s.e.m. Statistical 
analysis was performed using two-tailed t-tests. n.s., not significant.
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(Fig. 4b–e and Supplementary Table 19). Furthermore, 9 TE copies 
were upregulated at H2, 16 at H16 and 17 at D3, indicating that less 
TE copies were upregulated in comparison to WT HSCs (Fig. 4f 
and Supplementary Table 20). The proximity of TE copies to genes 
was not significant at any time point. Thus, it is possible that MDA5 
has a role in TE upregulation. Collectively, TEs are upregulated in 
Mda5−/− HSCs following similar patterns to WT HSCs, albeit with 
some differences.
Inflammatory signalling is impaired in Mda5−/− HSCs after 
chemotherapy. Next, we reasoned that an impaired inflammatory 
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Fig. 4 | TE upregulation in Mda5−/− HSCs after chemotherapy. a, Heat map of the log2-transformed fold change of all differentially expressed TE families 
detected in Mda5−/− HSCs at the indicated time points after 5-FU treatment. TE families that had a significantly enriched or depleted ATAC-seq peak 
nearby (±1 kb) are highlighted in the right column (A). b, The number of upregulated or downregulated TE families in Mda5−/− HSCs at the indicated time 
points after 5-FU treatment. c, t-SNE representation of sorted Mda5−/− HSCs (LSK/SLAM) at D0 (red) and H16 (dark red) (the number of sequenced 
cells is indicated in parentheses). d, t-SNE representation showing the expression of differentially expressed TE families between H16 and D0 in Mda5−/− 
HSCs. The colour scale represents the log2-transformed normalized transcript counts. e, The log2-transformed fold change in expression of the TE families 
shown in d at D0 or H16 in Mda5−/− HSCs from c. The box shows the interquartile range, the whiskers show the minimum and maximum values, and 
the horizontal line shows the median value. Each dot represents a single cell and the shape of the plot represents probability density. n = 648 (D0) and 
n = 1,185 (H16) Mda5−/− cells. One independent experiment per time point. Padj < 0.05. f, Heat map of the expression values (fold change) of TE copies in 
Mda5−/− HSCs at the indicated time points compared to D0. Fold change cut-off = 1.5. Padj < 0.05.
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Similar to the WT, gene upregulation was observed while some 
inflammatory signalling pathways were enriched (fold change 
cut-off = 1.5; Padj < 0.05; Extended Data Fig. 4a,b and Supplementary 
Tables 21–23). By comparing the expression of Mda5−/− HSCs at 
H16 versus D0 at the single-cell level, we found that inflammatory 
genes are expressed at higher levels at H16 together with activation 
markers, such as Cdk6, and enrichment for inflammatory signalling 
pathways was observed (Extended Data Fig. 4c–e). We next com-
pared the WT and Mda5−/− HSCs at the single-cell level (Extended 
Data Fig. 4f,g). GSEA analysis of the whole dataset revealed that 
cell-cycle-associated genes are enriched in the WT HSCs at D0, 
while Cdk6 expression was significantly less in Mda5−/− HSCs at 
H16 (Extended Data Fig. 4h–j and Supplementary Tables 24–26). 
IRG upregulation in the bulk RNA-seq data was blunted in Mda5−/− 
HSCs in comparison to WT HSCs (Fig. 5a). Thus, transcriptional 
changes in Mda5−/− HSCs compared with WT HSCs suggest that 
the IFN response is impaired in Mda5−/− HSCs.
ATAC-seq assays revealed that, in Mda5−/− HSCs, as in WT cells, 
numerous genomic regions gain accessibility from H2 onwards 
while some of these regions begin to compact from D3 onwards 
(Fig. 5b,c and Supplementary Tables 27–31). A significant number 
of deregulated genes also showed changes in chromatin accessibil-
ity at all time points (Extended Data Fig. 4k). Motif occupancy of 
inflammatory transcription factors in Mda5−/− HSCs at H2, H16 
and D3 was significantly reduced compared with that of WT HSCs 
(Fig. 5d). Through comparison of the accessible regions between 
WT and Mda5−/− HSCs at H16, we observed many regions that are 
unique to either WT or Mda5−/− HSCs (Fig. 5e). By assigning these 
regions to adjacent genes (±25 kb) and performing upstream regu-
lator analysis at the genes adjacent to uniquely accessible regions 
at WT HSCs, we found regulators such as LPS and IFNγ that were 
absent when the same analysis was performed for the uniquely 
accessible regions of Mda5−/− HSCs (Extended Data Fig. 4l).
Next, we investigated whether inflammatory signalling is dereg-
ulated beyond the transcriptional level. Immunostaining analysis at 
H16 and D3 after treatment with 5-FU revealed that the levels of 
phosphorylated IRF3 (the active form of IRF3) were decreased in 
Mda5−/− HSCs compared with WT HSCs at H16, but were simi-
lar at D3 (Fig. 6a and Extended Data Fig. 5a). The concentration 
of IFNβ, a type-I IFN that is induced directly by MDA5 signalling, 
was reduced in Mda5−/− BM serum at D3, but not at H16 (Fig. 6b). 
Other cytokines, such as IL1a, IL23, IL10 and IL26, were also sig-
nificantly increased in WT, but not in Mda5−/−, BM supernatant at 
D3, while few significant differences were observed at other time 
points (Extended Data Fig. 5b,c). The translocation of p65 to the 
nucleus was decreased in Mda5−/− HSCs at H16 in comparison to 
the WT (Fig. 6c,d). Thus, inflammatory signalling is impaired in 
Mda5−/− HSCs, potentially explaining their impaired activation 
after chemotherapy.
MDA5 signalling regulates HSC activation in a cell-intrinsic man-
ner. As Mda5 is knocked out in all tissues, we examined whether 
the phenotype of Mda5−/− HSCs is cell intrinsic. Knockdown of 
Mda5 in HSCs in vitro led to enhanced colony-forming-unit capac-
ity, indicating that the function of MDA5 in HSCs is cell intrinsic 
(Fig. 7a–c). We next performed transplantation experiments of 
WT HSCs into Mda5−/− or WT mice. We used these transplanted 
animals to perform the following secondary challenges: transplan-
tation to secondary WT or Mda5−/− recipients or repeated 5-FU 
injections every 10 d. Nevertheless, we found no significant differ-
ences between HSCs hosted into Mda5−/− or WT mice (Fig. 7d,e). 
Next, we examined whether BM haematopoietic cells could contrib-
ute to the activation of HSCs. We performed transplantations with 
mixed WT and Mda5−/− BM cells at different ratios (85:15, 50:50, 
15:85) and, 2 months after transplantation, we challenged the mice 
with 5-FU and performed cell cycle analysis 4 d after. The 50:50 
chimaeras showed that Mda5−/− HSCs remain more quiescent than 
their WT counterparts (Fig. 7f). The ability of WT HSCs to exit qui-
escence after chemotherapy did not change even when 85% of the 
cotransplanted BM was Mda5−/− (Fig. 7f). Furthermore, Mda5−/− 
HSCs retained their quiescence even when 85% WT BM cells were 
co-transplanted (Fig. 7f).
We also investigated whether TE families and inflammatory sig-
nalling are upregulated at H16 after chemotherapy in myeloid cells 
(Mac1+Gr1+) from WT and Mda5−/− mice. There was no upregula-
tion of TE families in WT or Mda5−/− myeloid cells in contrast to 
HSCs. Concomitantly, only 11 genes were upregulated and 21 were 
downregulated in WT myeloid cells, and 37 genes were upregulated 
and 92 downregulated in Mda5−/− myeloid cells in comparison to 
hundreds of deregulated genes in HSCs (fold change cut-off = 1.5; 
Padj < 0.05; Supplementary Tables 32–34). Few upregulated IRG 
genes were identified in WT or Mda5−/− myeloid cells (Fig. 7g). 
These results show that the role of MDA5 in HSC activation is 
mostly cell intrinsic.
Overexpression of TEs leads to HSC activation, whereas 
knockdown favours HSC quiescence. As MDA5 is activated by 
double-stranded RNA ligands such as polyinosinic:polycytidylic 
acid (poly(I:C))5,31, we reasoned that poly(I:C) should be able 
to induce WT HSCs, but not Mda5−/− HSCs, to exit quiescence. 
Indeed, 24 h after injection, a significant proportion of Mda5−/− 
HSCs remained in G0 compared with WT HSCs, and a reduced 
accumulation of γH2AX foci was observed in Mda5−/− HSCs (Fig. 
8a and Extended Data Fig. 6a). We next verified that TE tran-
scripts are indeed important for HSC activation by MDA5. Ex vivo 
decitabine treatment (which is known to cause TE transcriptional 
activation29,33) of HSCs for 72 h led HSCs to exit from the quiescent 
G0 state and enter cell cycle (Fig. 8b). Notably, we also examined 
the role of SETDB1, which is a known regulator of TE silencing34,35, 
in haematopoietic regeneration after chemotherapy. qPCR analysis 
of Setdb1 showed that it was downregulated after treatment with 
5-FU, but knockdown of Setdb1 in cultured HSCs resulted in cell 
cycle stalling and only one upregulated TE family, in agreement 
with previous studies36 (Extended Data Fig. 6b,c and Supplementary 
Table 35). However, the expression results may understimate the 
upregulated TE families since we did not observe significant down-
regulation of Setdb1 on the RNA-seq, as is sometimes the case in 
experiments using siRNAs.
We next reasoned that overexpression of TE copies should lead 
to HSC cycling and activation of inflammatory signalling. We over-
expressed both strands of three different TE copies that were found 
to be transcriptionally upregulated in HSCs after 5-FU treatment 
in our bulk or single-cell RNA-seq data, namely, MLTR18C_MM, 
RLTR1B, and a fragment of LINE1. Using qPCR, we verified the 
Fig. 5 | Impaired inflammatory signalling in Mda5−/− HSCs. a, Heat map of the normalized fold change in the union of IRGs upregulated in control WT or 
Mda5−/− HSCs at the H2, H16 or D3 time points compared to D0. Fold change cut-off = 1.5. Padj < 0.05, at least at one time point. b,c, Heat map (left) of 
the common and differentially accessible regions in Mda5−/− HSCs at D0, H2, H6 and H16 (b) or at D0, H16, D3 and D10 (c) ±3 kb from the centre of the 
peak. Right, the genomic location distribution of the accessible regions in each cluster of the heat map. d, Average normalized Tn5 insertion profiles around 
footprinted motifs (p65, IRF3, STAT1) in merged ATAC peaks at the indicated time points after 5-FU treatment in WT or Mda5−/− HSCs. Footprint numbers 
(n) are indicated at the top. Footprint occupancy scores indicate significance versus D0. Insertions on the forward and reverse DNA strands are indicated 
in red and blue, respectively. e, Heat map of common and differentially accessible regions in WT and Mda5−/− HSCs at H16.
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overexpression of TE copies (Extended Data Fig. 6d). By overex-
pressing GFP as a control-coding gene, we observed no difference in 
the activation of WT HSCs (Extended Data Fig. 6e). Expression of 
MLTR18C_MM and LINE1 fragment but not RLTR1B in WT HSCs 
led to the activation of inflammation, as reflected by qPCR analy-
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secretion of cytokines in the milieu (Fig. 8c and Extended Data Fig. 
6f). In accordance, overexpression of MLTR18C_MM and LINE1, 
but not RLTR1B, was sufficient to decrease the percentage of G0 WT 
HSCs in comparison to HSCs transfected with an empty vector (EV) 
(Fig. 8d). On the contrary, overexpression of the same elements in 
Mda5−/− HSCs did not significantly change the number of cells in 
G0 compared to EV-transfected cells nor did it induce upregula-
tion of inflammatory genes in sorted and transfected Mda5−/− HSCs 
(Fig. 8d,e). Knockdown of LINE1 with three different short-hairpin 
RNAs (shRNAs) that affect the expression of all recent LINE1 
families, L1Md_A, L1Md_Gf and L1Md_T led to enhanced HSC 
quiescence as more HSCs remained in G0 (Fig. 8f and Extended 
Data Fig. 6g). Thus, it is possible that TEs have a functional role in 
haematopoietic regeneration through activation of MDA5.
MAVS, TBK1 and STING are required for HSC activation. MDA5 
is not the only sensor present in HSCs and therefore, in theory, other 
sensors or downstream proteins could also affect HSC activation 
after stress. We treated WT HSCs with an inhibitor of TBK1 kinase, 
which is downstream of MDA5, RIG-I and STING9,37. As inhibition 
Fig. 7 | Intrinsic role of Mda5 in HSCs. a, Serial CFU-C assays in WT HSCs transfected with a control or an Mda5 short interfering RNA (siRNA) pool. 
Colony counts were scored every 7 d. n = 12 technical replicates from n = 4 biologically independent experiments. Statistical analysis was performed using 
two-tailed t-tests. b, qPCR analysis of Mda5 expression in WT HSCs transfected with a control or an Mda5 siRNA pool. n = 4 biologically independent 
samples. c, Cell cycle analysis of HSCs transfected with a control (n = 4 biologically independent samples) or an Mda5 siRNA pool (n = 7 biologically 
independent samples). Data are mean ± s.d. Statistical analysis was performed using two-tailed t-tests. d, The percentage of donor-derived cells in the 
peripheral blood of WT or Mda5−/− primary recipients (week 4: n = 12 (WT) and n = 14 (Mda5−/−); and weeks 8, 12 and 16: n = 13 (WT and Mda5−/−) 
biologically independent samples) and secondary recipients (n = 8 (WT) and n = 7 (Mda5−/−) biologically independent samples). The dotted line separates 
the primary from secondary transplantation. Data are mean ± s.e.m. Statistical analysis was performed using two-tailed t-tests. e, Kaplan–Meier survival 
curve of WT or Mda5−/− primary recipient mice after 5-FU injections every 10 d, 16 weeks after intravenous injection of total BM cells from WT mice. n = 8 
mice. Statistical analysis was performed using the log-rank (Mantel–Cox) test; n.s., not significant. f, The cell cycle status of HSCs in chimaeras injected 
with the indicated ratios of WT and Mda5−/− BM. Left, WT HSCs gated on CD45.1+CD45.2+ (CD45.1.2) cells. Right, Mda5−/− HSCs gated on CD45.2+ cells, 
and the BM composition is indicated below. The groups were injected with 5-FU 4 d before the analysis. Data are mean ± s.d. No 5-FU: n = 4; with 5-FU: 
n = 6 (15:85), n = 5 (50:50), n = 9 (85:15) biologically independent samples in n = 2 independent experiments. Statistical analysis was performed using 
two-tailed t-tests. g, Heat map of the normalized fold change in the union of IRGs that are upregulated in WT HSCs and in WT myeloid (Myelo.) cells or 
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Fig. 6 | 5-Fu-induced inflammation is MDA5-dependent. a, Relative changes in median fluorescence intensity (MFI) of phosphorylated IRF3 (pIRF3) 
in WT or Mda5−/− HSCs at D0, H16 or D3 after 5-FU treatment, normalized to the WT D0. n = 8 biologically independent samples in n = 3 independent 
experiments (D0), n = 10 biologically independent samples in n = 3 independent experiments (H16) and n = 4 biologically independent samples in one 
experiment (D3). Each dot represents one mouse. Data are mean ± s.d. Statistical analysis was performed using two-tailed t-tests; n.s. not significant.  
b, The amount of IFNβ (pg ml−1) measured in the BM serum of WT or Mda5−/− mice at D0, H16 or D3 after 5-FU treatment. Each dot represents one 
mouse. n = 14 (D0), n = 6 (H16), n = 10 (D3) biologically independent samples in n = 2 (D0 and D3) and n = 1 (H16) independent experiments. Data are 
mean ± s.d. Statistical analysis was performed using two-tailed t-tests; n.s., not significant. c, The integrated density of the NF-κB subunit p65 in the 
cytoplasm and the nucleus of WT or Mda5−/− HSCs at H16 after 5-FU treatment. n = 129 (WT) and n = 132 (Mda5−/−) HSCs examined in n = 2 independent 
experiments. Statistical analysis was performed using two-tailed t-tests; n.s., not significant. d, Immunostaining for NF-κB subunit p65 in WT or Mda5−/− 
HSCs at D0 and H16 after 5-FU treatment. n = 2 independent experiments. Scale bar, 5 μm. The histograms on the right represent the grey value intensity 
of both p65 (green) and Hoechst (blue) as indicated in the figure by the red dashed line.
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of TBK1 has been reported to affect the spindle assembly during 
mitosis38, we titrated the TBK1 inhibitor BX795 and used a concen-
tration that does not affect the cell cycle. TBK1 inhibition led to an 
increase in the number of CFU-C colonies after replating (Fig. 8g 
and Extended Data Fig. 6h). Furthermore, knockout of Mavs, which 
encodes a downstream adaptor protein, or Sting, which encodes a 
DNA-sensing-associated molecule, showed that a greater percent-
age of Mavs−/− or Sting−/− HSCs remain in G0 in comparison to WT 
HSCs (Fig. 8h). These results show that DNA-sensor signalling 
through STING and signal mediators downstream of MDA5 and 
RIG-I regulate HSC activation.
Collectively, our results show that chromatin accessibility 
changes after chemotherapy are followed by TE transcriptional 
upregulation. TEs activate the RNA sensor MDA5 to induce inflam-
matory signalling and HSC proliferation (Extended Data Fig. 7).
Discussion
Our findings show that TEs, mainly ERVs and LINEs, are tran-
scriptionally upregulated after chemotherapy and act as ligands for 
MDA5 to trigger an inflammatory response that results in HSCs 
exiting quiescence. Note that inverted Alu repeats were shown to 
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not identify such elements as deregulated after chemotherapy, it 
is possible that expression data of higher depth will reveal such 
deregulation. Moreover, further studies are needed to examine 
whether TEs expressed after chemotherapy are single-stranded, or 
double-stranded due to either bidirectional transcription or forma-
tion of double-stranded stretches.
Another outstanding question is the regulation of TE transcrip-
tion after chemotherapy. We show that SETDB1—a well-known 
regulator of TE silencing34,35,39—is transcriptionally downregulated 
after chemotherapy but its knockdown in cultured HSCs did not lead 
to HSC activation. However, the role of SETDB1 may be different in 
























































































































































































































































Fig. 8 | TE overexpression leads to HSC activation and knockdown leads to quiescence. a, Cell cycle analysis of WT or Mda5−/− HSCs 24 h after poly(I:C) 
injection. n = 4 biologically independent samples. Data are mean ± s.d. Statistical analysis was performed using two-tailed t-tests. b, Cell cycle analysis 
of WT HSCs 72 h after decitabine (DAC) treatment or without DAC (control). n = 3 biologically independent samples. Data are mean ± s.d. Statistical 
analysis was performed using two-tailed t-tests. c, qPCR analysis of IRGs in WT HSCs transfected with an EV or different TE copies (both strands) as 
indicated. n = 2 biologically independent samples and experiments. d, The fold change relative to WT transfected with an EV of WT or Mda5−/− HSCs 
in G0 or cycling after transfection with EV or the indicated TE copies (both strands). n = 6 biologically independent samples and experiments. Data are 
mean ± s.d. Statistical analysis was performed using two-tailed t-tests; n.s., not significant. e, qPCR analysis of IRGs in Mda5−/− HSCs transfected with an 
EV or the indicated TE copies (both strands). n = 2 biologically independent samples and experiments. f, Cell cycle analysis of WT HSCs after transfection 
with control shRNA or knockdown of LINE1 with three different specific shRNAs. n = 3 biologically independent experiments with n = 2 replicates each. 
Statistical analysis was performed using two-tailed t-tests. Data are mean ± s.d. g, Serial CFU-C assay of BM HSCs from WT mice cultured for 48 h in the 
absence (WT) or presence of 1 μM TBK1 inhibitor (WT BX795). Colony counts were scored every 7 d. Representative of n = 2 independent experiments 
(n = 3 technical replicates). h, Cell cycle status of WT (n = 5 biologically independent samples) or Mavs−/− (n = 11 biologically independent samples) or 
Sting−/− (n = 3 biologically independent samples) HSCs determined by flow cytometry with Ki67 and Hoechst staining. n = 2 independent experiments. 
Data are mean ± s.d. Statistical analysis was performed using two-tailed t-tests.
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signalling also regulates TE transcription40,41, and co-evolution of 
TEs and immune genes has been established42 in agreement with the 
observed differences in TE deregulation between WT and Mda5−/− 
HSCs. Our findings are consistent with previous research showing 
that TEs are upregulated in HSCs after irradiation. However, in that 
study, a thrombopoietin-induced IFN-like response was shown to 
restrain LINE1 activity21. Our data indicate a second wave of IFN 
gene expression at D10 that could restrain TE transcription. Finally, 
phenomena such as pervasive transcription43 may influence TE 
transcription and need further delineation. It will also be interesting 
to examine whether editing by ADAR or RNA methylation occurs 
in TEs after chemotherapy as both mechanisms have been shown to 
prevent MDA5 activation11,44,45.
As inflammatory signalling is central to HSC activation, it is 
conceivable that other RIG-I-like receptors, particularly RIG-I, 
DNA-sensing pathways such as cGAS-STING or inflammasome 
components could have similar roles in haematopoietic regenera-
tion. Indeed, it has been shown that the RIG-I is more abundant in 
multipotent haematopoietic progenitors versus myeloid cells46 and 
STING activation leads to HSC mobilization47, while NLRP3 has a 
role in HSC emergence48. The activation of DNA-sensing pathways 
was recently shown to be caused by R-loops in HSC development49. 
Our data suggest a role for different sensors in HSC activation. 
However, the role of MDA5 in haematopoietic regeneration may 
also depend on other functions besides its role in inducing inflam-
mation, as activation of MDA5 has been associated with endoplas-
mic reticulum stress50, metabolism51 and autophagy52.
We have previously shown that an interplay between TEs and 
RIG-I-like receptors enhances HSC formation in a non-stress devel-
opmental setting53. Our data suggest that this TE–MDA5 coupled 
mechanism may also function under homeostatic conditions in the 
BM, as HSCs lacking MDA5 are more resistant to activation under 
homeostasis. We propose that the TE–MDA5 signalling axis buffers 
mild homeostatic or robust stress signals by titrating inflammatory 
signals that modulate HSC activation. Several other stress signals, 
including ageing20 and heat shock stress17 also activate TE expres-
sion. Thus, it is plausible that TE sensing by RNA/DNA sensors is 
a phenomenon that is used by diverse cell populations to respond 
to challenges.
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Methods
Cell lines. HEK293T and OP9 cells were maintained at 37 °C and 5% CO2 and 
cultured in DMEM or alphaMEM containing glutamine (Gibco) respectively, 
supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin.
Mice. All mouse experiments were carried out in accordance with the guidelines of 
the Federation of European Laboratory Animal Science Association and following 
legal approval of the Regierungspräsidium Freiburg (35/9185.81/G-15/100, 35-
9185.81/G-18/41, 35-9185.81/G-18/127, 35-9185.81/G-20/127). Mda5−/− mice (B6.
Cg-Ifih1tm1.1Cln/J)31 were purchased from the Jackson Laboratory and backcrossed into 
C57BL/6J WT mice (CD45.2+/Ly5.2). Sting−/− mice bones (B6(Cg)-Sting1tm1.2Camb/J)54  
and Mavs−/− mice bones (Mavstm1Tsc)55 and their respective controls were a gift  
from J. Rehwinkel. All of the animals were maintained at the animal facility  
of the Max Planck Institute of Immunobiology and Epigenetics under specific- 
pathogen-free conditions in individually ventilated cages with a light–dark  
cycle of 12 h–12 h at 20–24 °C under 45–65% humidity. For all genotypes, gender- 
matched female or male mice (aged 6 to 12 weeks), or bones, were used  
in the experiments.
Antibodies, except for the LINE1-knockdown experiment. The following 
antibodies were purchased from BioLegend and used at a 1:400 dilution unless 
indicated otherwise: anti-CD45.1/Ly5.1 (APC-Cy7, A20), anti-CD45.2/Ly5.2 
(Alexa Fluor 700, 104), anti-CD3e (FITC, 145-2C11), anti-CD11b/Mac-1 (1:1,600, 
FITC or PerCP-Cy5.5, M1/70), anti-Ly6C/Ly6G (1:1,600, FITC or PerCP-Cy5.5, 
RB6-8C5), anti-CD45R/B220 (FITC or APC, RA3-6B2), anti-Ter119 (FITC, Ter-
119), anti-CD117/c-kit (Brilliant Violet 421 (1:600) or PE; BioLegend, or APC-H7, 
2B8, (1:200) BD Bioscience), anti-Sca-1 (Pe-Cy7, E13-161.7), anti-CD48 (1:800, 
PerCP-Cy5.5, HM48-1), anti-CD150 (1:600, PE-Dazzle or 1:600 Brilliant Violet 
605, TC15-12F12.2), anti-CD135/Flk2 (1:200, PE, A2F10.1, BD Pharmingen), 
anti-CD34 (1:30, Alexa Fluor 700 RAM34, eBioscience), anti-Ki67 (1:200, Alexa 
Fluor 647, 11F6), anti-CD201 (1:200, EPCR, PE anti-mouse, RCR16), anti-p-IRF3 
(1:25, S396, D601M, rabbit monoclonal antibody 29047, Cell Signaling), goat 
anti-rabbit secondary (1:500, Alexa Fluor 647, A21245, Invitrogen), anti-γH2AX 
(1:100, Alexa Fluor 647 (Ser 139), 2F3) and anti-p65 (1:100, Alexa Fluor 488, p65, 
Santa Cruz Biotechnologies) antibodies.
Sorting strategy. Throughout the text, HSCs refer to LSK/SLAM cells (Lin−Sca1+
cKit+CD150+CD48−) or EPCR/SLAM unless indicated otherwise. LT-HSCs: LSKC
D34−CD135−CD150+CD48−; MPP1: LSKCD34+CD135−CD150+CD48−; MPP2: LS
KCD34+CD135−CD150+CD48+; MPP3: LSKCD34+CD135−CD150−CD48+; MPP4: 
LSK CD34+CD135+CD150−CD48+.
HSC quantification and sorting by flow cytometry. For HSC quantification, 
tibiae, femurs and hip bones were crushed in staining buffer (PBS, 2% FBS, 1 mM 
EDTA). Erythroid cells were lysed in an ammonium-chloride-potassium buffer 
(150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) for 5 min at room temperature. 
Cells were washed, resuspended in staining buffer and counted using a Casy 
Cell counter. For sorting, samples were enriched for HSCs by lineage depletion 
using a biotin-conjugated lineage cocktail (CD3e, CD11b/Mac-1, CD45R/B220, 
Ly-6/Ly6C, TER-119) for 20 min at 4 °C. Streptavidin nanobeads (MojoSort, 
BioLegend) were added for 20 min at 4 °C followed by magnetic separation for 
4 min at room temperature. Then, 107 cells per ml were stained with antibodies 
against CD117/c-kit, Sca-1, CD48, CD150 and, if indicated, CD135/Flk2, CD34 or 
EPCR, CD48 and CD150 for 20 min at 4 °C (for CD34, 90 min at 4 °C). Cells were 
washed, resuspended in 500 µl of staining buffer, and data were either acquired on 
a Fortessa FACS analyser or sorted using a FACS ARIAIII or FACS ARIAFusion 
(BD Biosciences). CD11b/Mac-1 was excluded after 5−FU or poly(I:C) injections. 
All data were analysed using FlowJo v.10.6.1.
HSC culture. HSCs or lineage-negative cells were cultured in StemPro-34 medium 
with 2.5% StemPro-34 Supplement, (106439011, Gibco), 50 ng ml−1 mSCF, 25 ng ml−1 
mTPO, 30 ng ml−1 mFlt3L, 1% penicillin–streptomycin and 2 mM l-glutamine.
Transplantation experiments. WT mice and Mda5−/− mice (CD45.2+/Ly5.2) were 
used as donors, WT mice (CD45.1+/Ly5.1) were used as competitors and WT 
mice (CD45.1+/CD45.2+) were used as recipients. No difference in engraftment 
was observed between CD45.1 and CD45.2 mice. When Mda5−/− mice were used 
as recipients, WT mice (CD45.1+/CD45.2+) were used as donors and WT mice 
(CD45.1+/Ly5.1) were used as competitors. Transplantations were conducted at a 
1:1 ratio of donor and competitor HSCs (LSK/SLAM). For primary transplantation, 
we estimated the number of HSCs in the BM and intravenously injected BM 
corresponding to 250 donor and competitor HSCs into lethally irradiated (9.5 Gy) 
recipients. For secondary transplantations, 3 × 106 total BM cells from primary 
recipients with similar chimerism were transplanted into lethally irradiated 
(9.5 Gy) recipients. Peripheral blood chimerism was checked every 4 weeks for 
16 weeks. For the mixed chimaera experiments, 30 × 106 total BM cells from 
WT (CD45.1+/CD45.2+) and Mda5−/− (CD45.2+/Ly5.2) mice at different ratios 
were intravenously injected into lethally irradiated (9.5 Gy) WT (CD45.1+/Ly5.1) 
recipients. Then, 8 weeks later, recipients were injected intraperitoneally with 
150 mg kg−1 body mass 5-FU (Sigma-Aldrich, F6627) or PBS and BM cells were 
analysed after 4 d.
For HSC transplantation after culture, 200 HSCs (LSK/SLAM) were cultured 
for 48 h and each well was co-injected with 200,000 WT (CD45.1+/Ly5.1) BM cells 
into one recipient.
For engraftment, 20 µl of blood was obtained from the tail vein. Erythrocytes 
were lysed and after washing, samples were resuspended in 100 µl of staining 
solution for 20 min at 4 °C with anti-CD45.1/Ly5.1, anti-CD45.2/Ly5.2, anti-CD3e, 
anti-CD11b/Mac-1, anti-Ly6C/Ly6G, anti-CD45R/B220 and anti-Ter119 antibodies.
Homing assay. Mice were euthanized 16 h after transplantation, and the presence 
of donor cells (LSK) in the BM was addressed by flow cytometry using antibodies 
against CD45.1/Ly5.1, CD45.2/Ly5.2, CD117/c-kit, Sca-1, CD3e, CD11b/Mac-1, 
CD45R/B220, Ly-6/Ly6C and TER-119, and a cocktail of FITC lineage antibodies.
Side population staining. In brief56, 107 BM cells per ml were resuspended in 
DMEM with penicillin–streptomycin, 10 mM HEPES and 2% FBS. Hoechst 33342 
(B2261, Sigma-Aldrich) was added at 5 µg ml−1 for 90 min at 37 °C. After washing, 
cells were stained with anti-CD117/c-kit, anti-Sca-1 and anti-CD150 antibodies in 
staining buffer at 4 °C for 20 min. Cells were resuspended in cold HBSS (14170-112, 
Gibco Invitrogen) with 10 mM HEPES and 2% FBS. Propidium iodide (2 µg ml−1; 
P-4170, Sigma-Aldrich) was added before analysis.
siRNA knockdown of Mda5. Lineage-negative cells from WT or Mda5−/− mice 
that were cultured as described above were transfected with DharmaFECT1 (T-
2001-02, Dharmacon) with 50 nM control non-targeting or Mda5 or Setdb1 siRNA 
(D-001810-10-05, L-065328-00-0005, L-040815-01-0005, Dharmacon) together 
with siGLO (D-001630-01-05). After 48 h, cells were collected and stained for LSK/
SLAM for 30 min at 4 °C in the dark. HSCs were fixed for cell cycle and sorted HSCs 
were used for CFU-C assays and RT–qPCR. In the case of Setdb1 knockdown, HSCs 
(LSK/SLAM) were sorted and processed for RNA-seq or cell cycle analysis.
CFU-C assays. LSK/SLAM HSCs (200) were sorted in a 96-well plate, cultured and, 
when indicated, incubated for 48 h with 1 µM BX795 (TBK1 inhibitor, 4318, Tocris). 
Each well was transferred into 900 μl of Mouse Methylcellulose Complete Media 
(HSC007, R&D systems), and split into 3 separate wells of a 24-well plate. Colonies 
were counted after 7 d at 37 °C and 5% CO2. For replatings, cells were washed with 
PBS and analysed by flow cytometry to estimate the number of LSK cells. LSK cells 
(200) were replated in fresh methylcellulose and counted after 7 d. For knockdown 
experiments, 150 HSCs were plated and counted after 7 d. Then, 10,000 cells per 
well were replated in fresh methylcellulose, and colonies were counted after 7 d.
5-FU, cytarabine, cyclophosphahmide and poly(I:C) treatment. 5-FU, cytarabine 
and poly(I:C) were injected intraperitoneally at 150 mg kg−1 (Sigma-Aldrich, 
F6627), 100 mg kg−1 (PHR1787, Supelco) and 10 µg g−1 (P9582, Sigma-Aldrich), 
respectively. Cyclophosphamide was injected intravenously at 200 mg kg−1 (C0768, 
Sigma-Aldrich).
Decitabine treatment of HSCs. Lineage-negative cells were isolated and cultured 
as described above with the addition of 1 μM decitabine (A3656, Sigma-Aldrich) 
for 72 h. Cells were fixed for cell cycle analysis.
Mitochondrial mass and ROS quantification. BM cells were stained in StemPro 
34SFM medium with MitoTracker Green (M7514, Thermo Fisher Scientific) at 
50 nM for 15 min at 37 °C or with CellRox Deep Red reagent (C10422, Thermo 
Fisher Scientific) at 500 nM for 30 min at 37 °C. HSCs (LSK/SLAM) were stained, 
washed and analysed.
Cell cycle staining and phosphorylated IRF3 staining. HSCs (LSK/SLAM) were 
stained, sorted, washed and resuspended in fixed intracellular Fixation Buffer 
(00-8222-49, Thermo Fisher Scientific) for 10 min at 4 °C. Cells were washed and 
resuspended in permeabilization buffer (00-8333-56, Thermo Fisher Scientific) 
with anti-Ki67 antibodies and Hoechst 33258 (H3569, Life technologies) for 30 min 
at 4 °C or with anti-p-IRF3 antibodies overnight at 4 °C. For p-IRF3 staining, 
cells were washed with permeabilization buffer and stained with AlexaFluor647 
(A21245, Invitrogen) for 30 min at room temperature. Cells were washed with 
permeabilization buffer and analysed. The Zombie Fixable Viability Kit (423105, 
BioLegend) was used for dead cell exclusion in cell cycle staining.
γH2AX and p65 staining. HSCs (LSK/SLAM; 1,000 per slide) were sorted onto 
PolyPrep l-lysine-coated (Sigma-Aldrich) slides (Ibidi µ-slide) and fixed with 
intracellular fixation buffer (00-8222-49, Thermo fisher Scientific) for 10 min 
at 4 °C. Cells were washed and resuspended in permeabilization solution (00-
8333-56, Thermo Fisher Scientific) containing 0.1% BSA for 30 min at room 
temperature. Cells were stained overnight at 4 °C with γH2AX or p65 antibody. 
After washing, 1 µg ml−1 of Hoechst 33258 was added. Images were acquired using 
LSM880 (Zeiss), airyscan processed and analysed using Imaris v.9.2 spot detection 
algorithm (Bitplane). For p65 staining, the Hoechst channel image was used to 
manually detect individual nuclei. For each nucleus, we measured the integrated 
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p65 intensity inside the nucleus. A region of interest (ROI) corresponding to the 
entire cell was then obtained and the integrated p65 intensity inside the ROI was 
measured. The cytoplasmic integrated p65 intensity was obtained by subtracting 
the integrated p65 intensity inside the nucleus from the integrated p65 intensity 
inside the ROI. Alternatively, the pixel intensity (grey value) of p65 and Hoechst 
was measured along a line in the overlay plots and displayed as histograms.
Cytokine quantification. The LEGENDplex Mouse Inflammation Panel 
(BioLegend) was used according to the manufacturer’s instructions. In brief, after 
bone crushing, the cell suspension was centrifuged at 1,500 r.p.m. for 5 min at 4 °C. 
The BM serum was stored at −80 °C. Samples were diluted 1:1 and incubated with 
beads conjugated with the respective antibodies. For Extended Data Fig. 6d, 700 µl 
of supernatant was collected after 24 h of culture, cells and debris were excluded by 
centrifugation and samples were processed as described above.
Cell division assays. HSCs (LSK/SLAMCD135−) were single sorted in Terazaki 
microtest plates (654102, Greiner) in the medium described above. Then, 1 h after 
sorting, the presence of cells was verified and, 24 h and 48 h later, the number of 
cells per well was counted using Axio Vert.A1 (Zeiss).
TE overexpression experiments. MLTR18C_MM, RLTR1B and a part of LINE1 
were synthesized by and cloned in pCCAGGs-IRES-Puro (gift from the Jenuwein 
laboratory). Clones containing the sense or antisense sequences were verified by 
sequencing. Lineage− cells (4 × 106) were electroporated with 2 µg of sense and 
2 µg of antisense constructs using P3 Primary Cell 4D-NucleofectorTM XKitL 
(V4XP-3024, Lonza). pCCAGGs-IRES-Puro was used as an EV and pmaxGFP 
plasmid as transfection efficiency control. Then, 24 h after electroporation, HSCs 
(LSK/SLAM) were stained and fixed for cell cycle analysis or sorted and total 
RNA was isolated (D4013, Zymo) and reverse-transcribed using SuperScript III 
(18080-051, Invitrogen) or PrimeScript RT (RR047A, Takara). RT–qPCR reactions 
were performed using the TB Green Premix (RR42LR, Takara) in a StepOnePlus 
Real-Time PCR machine (Applied Biosystems). Expression was quantified over EV 
and normalized to the expression of HPRT or beta actin.
LINE-1 knockdown. BM was extracted from femur, pelvic bone, tibias and spine 
by crushing. c-Kit+ cells were isolated using magnetic anti-CD117 microbeads 
(130-091-224, Miltenyi Biotec) and an autoMACs magnetic cell-separator. For HSC 
(LSK/SLAM) isolation, cells were stained using an anti-lineage BV605 antibody 
cocktail (1:400) and antibodies against Sca-1 PerCPCy5.5 (122523, E13-161.7clone, 
BioLegend), c-Kit APCe780 (47-1171-82, clone 2B8, eBioscience), CD48-Alexa 
Fluor700 (56-0481-82, clone HM48-1, eBioscience) and CD150-PE-Cy7 (115913, 
clone TC15-12F12.2, BioLegend) (1:200 for the rest of the antibodies). DAPI was 
used for dead cell exclusion. Cell were sorted using the FACSAriaIII system. shRNAs 
were designed as previously described57,58. Vesicular stomatitis virus glycoprotein–
pseudotyped lentivirus was prepared using a four-plasmid system (Transfer vector-, 
Gag/Pol-, Rev/Tat-, and envelope plasmid) by cotransfection of HEK293T cells 
using TransIT293 (Mirus)58. Supernatant was collected 48 h later, cleared, titred onto 
HEK293T cells and stored at −80 °C. LSK cells from mice (aged 6–10 weeks) were 
transduced with lentivirus as described previously58. Non-tissue-culture 96-well plates 
were coated with Retronectin (TaKaRA Bio), and lentiviral particles (multiplicity of 
infection of 25) were spinoculated for 1 h at 1,000g at room temperature. Wells were 
washed with PBS, and 15,000 freshly isolated LSK cells were resuspended in 200 µl 
StemSpan (09600, StemCell Technologies) with recombinant mouse SCF (10 ng ml−1), 
TPO (20 ng ml−1), IGF2 (20 ng ml−1) (PeproTech), 10 ng ml−1 recombinant human 
FGF1 (R&D Systems) and 5 µg ml−1 protamine sulfate (Sigma-Aldrich). Then, 48 h 
after transduction, the medium was slowly removed, and the cells were washed and 
resuspended in PBS + 1.5% FBS. For cell cycle analysis, LSK cells transduced with 
control or L1 shRNAs and cultured for 5 d, at which point mCherry+ HSC (LSK/
SLAM) cell cycle was examined by flow cytometry using Ki67. Total RNA was 
isolated (74004, Qiagen) and reverse-transcribed (4368814, Invitrogen). To confirm 
that HSCs express full-length L1, purified mRNA was reversed transcribed using 
a sense-strand L1-specific primer recognizing the 3′ end of ORF2, as described 
previously59. qPCR was performed using the Fast SYBR Green Master Mix (Applied 
Biosystems) on an ABI StepOnePlus thermal cycler (Applied Biosystems). Gene 
knockdown efficiency in LSK cells was quantified using RT–qPCR.
Oligos and primers. A list of oligos and primers is provided in the last sheet of 
Supplementary Table 36.
RNA-seq. For RNA-seq (2–3 biological replicates per sample, 2,000cells per 
sample), HSCs (LSK/SLAM) from WT and Mda5−/− mice were sorted and 
RNA was isolated using either the PicoPURE Arcturus kit (KIT0204, Applied 
Biosystems) for HSCs or the RNeasy Mini Kit (74104, Qiagen) for myeloid cells. 
For HSCs, cDNA libraries were prepared using SMARTseqv4 (R400752, Takara) 
with 12 cycles of amplification. The NEBNext Ultra II FS DNA kit (E7805S) was 
used to generate barcoded sequencing libraries. cDNA library (3–10 ng) was 
fragmented for 22.5 min, adapters were ligated and libraries were amplified using 
cycle numbers according to input material. The NEB Next low input library kit 
(E6420) was used for the preparation of RNA-seq libraries from myeloid cells.
RNA-seq analysis of genes. Paired-end 101 bp reads for WT and Mda5−/− samples 
were generated using the Illumina Hiseq 3000 or NovaSeq 6000 system. Adapter 
sequences were trimmed using Trimmomatic (v.0.36)60 and then reads were 
aligned to mouse genome version GRCm38/mm10 using STAR aligner (v.2.5.3a)26. 
Samtools (v.0.1.19)61 was used for data filtering and file format conversion, while 
the HTseq count (v.0.5.4p3)62 algorithm was used to assign aligned reads to 
exons using the following command line: «htseq-count --s no --m intersection 
-nonempty». Differentially expressed genes were identified using the DESeq R 
package63, and genes with fold change cut-off of 1.5 and Padj < 0.05 were considered 
to be differentially expressed (DEGs). All times points were normalized together. 
Heat maps showing the normalized fold-change of deregulated genes were made 
in R using the gplots package (https://cran.r-project.org/package=gplots) and 
heatmap.2 function. Stack bar graphs representing the number of DEGs were 
constructed using the R package Shiny (https://shiny.rstudio.com/).
RNA-seq analysis of TE families. Analysis was performed as described 
previously64. Paired-end 101 bp reads for WT and Mda5−/− samples were generated 
using the Illumina Hiseq 3000 or NovaSeq 6000 system. Adapter sequences 
were trimmed with Trimmomatic (v.0.36)60 and then reads were aligned to 
GRCm38/mm10 using STAR aligner (v.2.5.3a)26 using the following options: 
-readFilesCommand -outFilterMultimapNmax 100 -winAnchorMultimapNmax 
100 -outMultimapperOrder Random -outSAMmultNmax 1 -outSAMtype BAM 
-outFilterTypeBySJou -alignSJDBoverhangMin 1 -outFilterMismatchNmax. Using 
the multimapped aligned files, TEtranscript (v.2.0.3)27 was used with the option 
--mode multi to estimate TE abundances. Annotation files were constructed from 
RepeatMasker (http://www.repeatmasker.org). Differentially expressed TE families 
were identified using the DESeq R package63, whereby TE families were normalized 
together with the genes. TE families with a fold-change cut-off of 1.5 and Padj < 0.05 
were considered to be differentially expressed. Heat maps showing expression of 
deregulated TE families were made in R using the pheatmap package65.
RNA-seq analysis of TE copies. Multimapped reads were filtered with Samtools 
MAPQ > 50 to extract the uniquely mapped reads. The HT-seq count (v.0.5.4p3.) 
algorithm62 was applied to assign aligned reads to the genomic instances of TE 
copies using the following command line ‘htseq-count --s no --m intersection 
--nonempty’. Annotation files were constructed from RepeatMasker (http://www.
repeatmasker.org). Differentially expressed TE copies were identified with the 
use of the DESeq R package63 (normalized pairwise to achieve good clustering), 
and TE copies with fold change cut-off of 1.5 and Padj < 0.05 were considered 
to be differentially expressed. Heat maps showing expression of deregulated 
TE copies were made in R using the gplots package (https://cran.r-project.org/
package=gplots) and heatmap.2 function.
TE copy gene proximity. The coordinates of the genomic regions of the upregulated 
TE copies were extracted from UCSC (https://genome.ucsc.edu/) and assigned to 
the closest gene using the closestBed subcommand of BEDtools --b mm10_tss.bed 
and the following parameters: -D ‘a’ -t ‘first’. By taking a window of 30 kb upstream 
and downstream from the TSS of the genes, we created a list of genes that were 
proximal to upregulated TE copies and selected the genes that were significantly 
deregulated in our RNA-seq analysis. Significance of the overlap was evaluated 
using the Fisher’s and hypergeometric tests. The expected background was 
determined by randomly sampling an equal number of the remaining genes and 
determining the number of genes located within 30 kb of the deregulated TE copies 
that were identified as proximal to deregulated genes. The parameter --exl was 
used to exclude gap files, blacklist regions, chrM and restrict the randomization 
within the corresponding genomic regions defined above. Sampling was repeated 
10,000 times and the mean number of overlaps from all of the shuffled datasets was 
used to determine the expected counts of overlaps with a binomial test, which was 
performed in R using the binom.test function.
ATAC-seq. For ATAC-seq (2 biological replicates per sample, ~5,000 cells per 
sample), HSCs (LSK/SLAM) were sorted and library preparation was performed 
exactly as described previously66 using the Nextera DNA Library Prep kit 
(15028212, Illumina).
ATAC-seq analysis. ATAC-seq paired-end 75 bp reads were generated using the 
Illumina Hiseq 3000 system. Adapter sequences were trimmed using Trimmomatic 
(v.0.36) and TrimGalore (v.0.4.3). Bowtie2 (v.2.1.0)67 using the «--very-sensitive» 
parameter was used for aligning ATAC-seq reads to GRCm38/mm10 and Samtools 
(v.0.1.19)61 for data filtering and file format conversion. Duplicate reads, blacklist 
regions and chrM were removed before peak calling. All filtered .bam files were 
converted to bedgraphs using the deepTools bamCoverage subcommand, with the 
reads per kilobase of transcript, per million mapped reads (RPKM) normalization 
method. MACS2 (v.2.1.0) algorithm68 was used for peak identification (P-value 
cut-off = 1 × 10−8). Gained peaks for each time point, compared to D0 were 
identified from the narrow peaks in two steps. First, the peak lists from two times 
points (for all time points compared to D0) were merged with the subcommands 
cat and mergeBed to obtain consensus peaks. Second, for each time point and 
with intersectBed and the parameters --a <consensus peaks> --b <narrow peaks> 
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The left read contains the barcode information: first six bases, unique molecular 
identifier (UMI); second six bases, cell-specific barcode; remainder read, polyT 
stretch. For each cell barcode, the number of UMIs per transcript was counted and 
aggregated across all transcripts derived from the same gene locus. On the basis 
of binomial statistics, the number of observed UMIs was converted into transcript 
counts79. For the quantification of TEs, to tag the reads according to UMI and 
cell barcode information, fastq files were processed using umitools v.0.5.1 with 
the flags bc-pattern=NNNNNNCCCCCC and filter-cell-barcode. The tagged 
fastq files were then mapped to the GRCm38 genome assembly using STAR 
v.2.5.3a with the following parameters --runThread 4 --readFilesCommand zcat 
--outFilterMultimapNmax 100 --winAnchorMulitmapNmax 100 --outSAMtype 
BAM SortedByCoordinate. The reads from the .bam files were then assigned 
to TEs using featureCounts from the subread-1.5.3 package together with the 
following parameters: --t exon --g gene_id --T 4 --R BAM and by using a .gtf 
file with annotated transposable elements (http://hammelllab.labsites.cshl.edu/
software/#TEtranscripts). The annotated data were sorted and indexed using 
Samtools v.1.6.0. TEs were counted per cell and gene using the count method 
from umitools v.0.5.1 with the flags --per-gene --gene-tag=XT --per-cell 
--wide-format-cell-counts. Clustering analysis and visualization were performed 
using the VarID algorithm80. Only cells with at least 2,000 gene transcripts or 
300 transcripts derived from TEs were retained. For genes, Cells expressing >2% 
of Kcnq1ot1, a potential marker for low-quality cells81, were not considered. 
Transcripts correlating to Kcnq1ot1 with a Pearson’s correlation coefficient >0.65, 
mitochondrial, ribosomal and predicted genes with Gm-identifiers were excluded. 
VarID was run with FSelect=TRUE, no_cores=4 and the default parameter 
otherwise. t-SNE was used for dimensionality reduction and data visualization. 
Differential gene and TE expression analysis was performed using the diffexpnb 
function of the RaceID3 algorithm similarly to a previously published method63. 
First, negative binomial distributions reflecting the gene expression variability 
within each subgroup were inferred on the basis of the background model 
for the expected transcript count variability computed by RaceID3. Using 
these distributions, a P value for the observed difference in transcript counts 
between the two subgroups was calculated and multiple testing corrected by 
the Benjamini–Hochberg method. GSEA was performed using gsePathway 
function of ReactomePA, an R/Bioconductor package82. The fold change for 
each gene was calculated using the diffexpnb function of VarID and was given 
as an argument to gsePathway function to calculate enriched gene sets using 
the following parameters: nPerm=1000, minGSSize=120, pvalueCutoff=0.05, 
pAdjustMethod=‘BH’, organism=‘mouse’.
FLASH. pMYS-MDA5-FHBH was generated by subcloning the human MDA5 
DNA sequence and the FHBH tag(3FLAG-6His-Biotin-6His) at the C-terminus 
of MDA5 into pMYS-IRES-GFP. HEK293T cells were transfected with 
pMYS-MDA5-FHBH or pMYS-GFP-FHBH with TurboFect (R0531, Thermo 
Fisher Scientific). The next day, cells were either irradiated (10 Gy) and collected 6 h 
later or treated with 1 μM decitabine (A3656, Sigma-Aldrich) for 72 h (exchanged 
daily). FLASH was performed as previously described28,83 and two replicates for 
each condition were sequenced using the NextSeq 500 system. The only difference 
with the published protocol is that washes after the streptavidin pull-down were 
performed with 0.1% SDS, 1 M NaCl, 0.5% LiDS, 0.5 M LiCl and 1% SDS, 0.5 M 
LiCl. For FLASH qPCR in HEK293 and OP9 cells, 100 µl input was taken before 
the first pull-down. After the streptavidin pull-down, the beads were treated with 
TurboDNase for 2 h for the input and 1 h followed by proteinase K (03115836001, 
Roche). Spike-in luciferase control RNA (15 pg μl) (L4561, Promega) was added and 
RNA isolation, cDNA and qPCR were performed as described above.
FLASH analysis. FLASH-seq data were demultiplexed using Flexbar (v.3.3)84. For 
each sample, UMIs were extracted using UMITools (v.0.5.1)85 followed by adapter 
removal with TrimGalore v.0.4.4. Potential readthroughs into the barcode and 
UMI region were removed by clipping the last 13 bases from the 3′ ends of first 
mate reads. The demultiplexed and processed reads were mapped to a ribosomal 
consensus sequence using Bowtie2 (ref. 67). Reads that did not map to the ribosomal 
sequence were mapped to hg38 using STAR (v.2.6.0b)26 using the parameters 
‘--winAnchorMultimapNmax 100 --outFilterMultimapNmax 100’. UMITools 
(v.0.5.1)85 was used to combine duplicated reads into individual cross-linking 
events. TEtranscripts (v.2.0.3)27 was run using both stranded options (--stranded 
reverse and --stranded yes). Gencode annotation (release 27) was used to define 
gene regions, and TETranscript was used for TE annotation. Fold change was 
calculated between different samples, and elements with a fold change of >1.5 and a 
P value < 0.05 (Welch approach test) were considered to be significantly bound. All 
.bam files were converted to bedgraphs with genomeCoverageBed a subcommand 
of BEDTools and were normalized using the RPKM normalization method. Graphs 
were generated with Prism6 (GraphPad Prism v.6.0e) (fold change cut-off of 1.5).
Statistics and reproducibility. For cell-based experiments, biological triplicates 
were used in each single experiment unless otherwise stated. For animal 
experiments, the sample size used was determined empirically according to 
the nature of the experiments and is stated in the figure legends. No statistical 
method was used to predetermine sample size. Age-matched male and female 
--wa --u and subsequently --v, we compare and subtract them, to take the gained 
and lost peaks for each time point compared to D0. The reads of these consensus 
peaks were counted and a statistical model based on edgeR69 was used to identify 
the significantly differential peaks. To identify the common peaks between the 
time points, DESeq which uses the Negative Binomial distribution to compute a P 
value and a fold change for each estimated peak was used. Peaks highly enriched 
in comparison to the rest were considered gained. Annotation of peaks to genes 
(100 kb upstream and 25 kb downstream from the TSS) and genomic distribution 
of accessible regions identified by MACS2 was performed using BEDTools and the 
-closetBed and -intersectBed subcommands, respectively. Clustering of regions was 
generated with the ComputeMatrix function of DeepTools70, using the reference 
point --referencePoint center -b 3000 -a 3000 -R <bed files> -S <bigwig files> as 
parameters, except for the WT versus Mda5−/− comparison, for which we used the 
following pararameters as the reference-point: --referencePoint center -b 2500 -a 
2500. The function plotHeatmap from the same package was used for displaying 
the average profiles heat map.
Digital genomic footprinting for ATAC-Seq. The produced .bam files from 
ATAC-seq data were merged using samtools merge (v.1.3.1)61. Digital genomic 
footprinting was performed using dnase_footprints of the Wellington pyDNase 
package (v.0.2.4)71 on total merged ATAC peaks with a P-value cut-off of 1 × 10−5, 
using -A as a parameter to enable ATAC mode, resulting in a coordinate shift 5′ 
and 3′ by +4 bp and −5 bp, respectively. Motif overrepresentation and average 
profile analyses were performed using dnase_average_profile.py of the Wellington 
pyDNase package71, on WT-only and WT versus Mda5−/− footprints. For 
calculating the footprinting occupancy scores, a Python script from Wellington 
pyDNase package (wellington_score_heatmap.py) was used. First, footprinting 
occupancy scores were log2-transformed and then two-tailed paired t-tests were 
performed in R, as if each value corresponds to the same chromosomal region, and 
not assuming any direction in the relationship between both samples.
ATAC-seq analysis of TEs. Adapter sequences were trimmed using Trimmomatic 
v.0.36 and TrimGalore v.0.4.3. Reads were mapped to GRCm38/mm10 using the 
Bowtie2 algorithm (v.2.1.0)67, using the «--very-sensitive» parameter enabling 
multiple mapping. Samtools61 filtering MAPQ > 10 was performed and all .bam 
files were converted to bedgraphs using the deepTools bamCoverage subcommand, 
dividing them into bins of size 50 and using the RPKM normalization method. 
Reads mapping to mitochondrial DNA or black-list regions were discarded. 
Significantly enriched peaks were detected using the MACS2 (v.2.1.0) algorithm68 
with a P-value cut-off of 1 × 10−5. Peaks with a size OF smaller than 300 bp were 
discarded. Gained peaks for each time point, compared to D0, were identified 
as described above. Annotation files were constructed from RepeatMasker. 
Differentially accessible open chromatin regions were scanned for enriched 
short-sequence motifs using HOMER software59 with the ‘findMotifsGenome.
pl’ command. To determine the enrichment (or depletion) of ATAC peaks nearby 
each TE family in relation to the genomic abundance of such families (compared to 
a random shuffling of such TEs), we used the Perl script TE-analysis_Shuffle_bed.
pl from the software TEanalysis72,73, (https://github.com/4ureliek/TEanalysis) with 
the following parameters: -l none -n 1000 -o 10 along with the TE bed file +1 kb 
upstream the beginning of each TE and 1 kb downstream the end of each TE. The 
significance of enrichment was estimated using binomial and hypergeometric 
tests. Subsequently, we evaluated the expression of each of the TE families within 
significantly enriched ATAC peaks.
Clustering of regions was generated using the ComputeMatrix function of 
DeepTools70 using the reference point --referencePoint center -b 2500 -a 2500 -R 
<bed files> -S <bigwig files> as parameters. The function plotHeatmap from the 
same package was used for displaying the average profiles heat map.
GO analysis and upstream regulator analysis. GO and pathway analysis was 
performed using Metascape (https://metascape.org/)74 (P ≤ 0.05). Upstream 
regulator analysis was performed through the use of IPA (QIAGEN Inc., https://
www.qiagenbioinformatics.com/products/ingenuitypathway-analysis).
Single-cell RNA-seq. Sorted HSCs (LSK/SLAM-cell numbers are shown in the 
figure legends) cells from two male mice per genotype and per condition were 
used. Single-cell RNA-seq was performed using the mCEL-Seq2 protocol, an 
automated and miniaturized version of CEL-Seq2 on a mosquito nanolitre-scale 
liquid-handling robot (TTP LabTech)75,76. Fifty-six libraries with 96 cells each 
were sequenced using the Illumina HiSeq 3000 or NovaSeq 6000 sequencing 
system (pair-end multiplexing run) at a depth of ~130,000–200,000 reads per 
cell. For quantification of transcript abundance, paired-end reads were aligned 
to the transcriptome using bwa (v.0.6.2-r126) using the default parameters77. The 
transcriptome contained all gene models on the basis of the mouse ENCODE 
VM9 (UCSC) comprising 57,207 isoforms, with 57,114 isoforms mapping to 
fully annotated chromosomes (1 to 19, X, Y, M). All isoforms of the same gene 
were merged to a single gene locus. Gene loci overlapping by >75% were merged 
to larger gene groups, resulting in 34,111 gene groups. The right mate of each 
read pair was mapped to the ensemble of all gene loci and to the set of 92 ERCC 
spike-ins in the sense direction78. Reads mapping to multiple loci were discarded. 
NATuRE CELL BIOLOGy | www.nature.com/naturecellbiology
ArticlesNATuRE CELL BIOLOgy
 72. Kapusta, A. et al. Transposable elements are major contributors to the origin, 
diversification, and regulation of vertebrate long noncoding RNAs. PLoS 
Genet. 9, e1003470 (2013).
 73. Lynch, V. J. et al. Ancient transposable elements transformed the uterine 
regulatory landscape and transcriptome during the evolution of mammalian 
pregnancy. Cell Rep. 10, 551–561 (2015).
 74. Tripathi, S. et al. Meta- and orthogonal integration of influenza ‘OMICs’ data 
defines a role for UBR4 in virus budding. Cell Host Microbe 18, 723–735 (2015).
 75. Hashimshony, T. et al. CEL-Seq2: sensitive highly-multiplexed single-cell 
RNA-Seq. Genome Biol. 17, 77 (2016).
 76. Herman, J. S., Sagar & Grun, D. FateID infers cell fate bias in multipotent 
progenitors from single-cell RNA-seq data. Nat. Methods 15, 379–386 (2018).
 77. Li, H. & Durbin, R. Fast and accurate long-read alignment with 
Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).
 78. Baker, S. C. et al. The external RNA controls consortium: a progress report. 
Nat. Methods 2, 731–734 (2005).
 79. Grun, D., Kester, L. & van Oudenaarden, A. Validation of noise models for 
single-cell transcriptomics. Nat. Methods 11, 637–640 (2014).
 80. Grun, D. Revealing dynamics of gene expression variability in cell state space. 
Nat. Methods 17, 45–49 (2020).
 81. Grun, D. et al. De novo prediction of stem cell identity using single-cell 
transcriptome data. Cell Stem Cell 19, 266–277 (2016).
 82. Yu, G. & He, Q. Y. ReactomePA: an R/Bioconductor package for reactome 
pathway analysis and visualization. Mol. Biosyst. 12, 477–479 (2016).
 83. Ilik, I. A., Aktas, T., Maticzka, D., Backofen, R. & Akhtar, A. FLASH: 
ultra-fast protocol to identify RNA-protein interactions in cells. Nucleic Acids 
Res. 48, e15 (2020).
 84. Roehr, J. T., Dieterich, C. & Reinert, K. Flexbar 3.0—SIMD and multicore 
parallelization. Bioinformatics 33, 2941–2942 (2017).
 85. Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in 
unique molecular identifiers to improve quantification accuracy. Genome Res. 
27, 491–499 (2017).
Acknowledgements
We thank the staff at the deep-sequencing, imaging, FACS, mouse and bioinformatics 
facilities of the MPI-IE; D. Ryan for discussions on TE analysis; M. Derecka for reading, 
advising and helping with overnight experiments; and A. Choudhuri, A. Karoutas, R. 
Grosschedl, T. Bowman and L. Zon for reading the manuscript. Funding: Max Planck 
Society (to E.T., N.C.-W., R.S. and D.G.), The Fritz Thyssen Stiftung (Az 10.17.1.026MN, 
to E.T.), the German Research Foundation (DFG) (Research Training Group 322977937/
GRK2344, to E.T. and D.G.; GZ: TR 1478/2-1, to E.T.; SPP1937 GR4980/1-1, to D.G.; 
GR4980/3-1, to D.G.), the DFG under Germany’s Excellence Strategy (CIBSS-EXC-
2189-Project ID 390939984, to E.T., D.G., N.C.-W. and R.S.), the ERC (818846—
ImmuNiche—ERC-2018-COG, to D.G., 759206-VitASTEM-ERC-Stg-2017 to N.C.-W., 
819753-ChaperoneRegulome-ERC-2018-COG, to R.S.), and the Behrens–Weise 
Foundation (to D.G.and N.C.-W.). J.R and R.S. acknowledge funding by the UK Medical 
Research Council (MRC core funding of the MRC Human Immunology Unit and the 
Toxicology Unit, respectively). Open access funding provided by Max Planck Society.
Author contributions
E.T. conceived the project. T.C. designed and performed experiments. A.P. performed 
the majority of computational analysis. P.P. designed and performed the FLASH 
experiments. P.P., L.K., N.K. S.L. and V.B. performed experiments. N.O. and N.C.-W. 
prepared the HSC RNA-seq libraries and provided advice. B.H. and D.M. performed 
analysis of the FLASH experiments. I.I. provided the protocol for the FLASH 
experiments and advice. R.B., R.S. and A.A. provided useful insights for the FLASH 
experiment and analysis. S. and D.G. performed and analysed the single-cell RNA-seq 
experiments. J.S.H. provided the code for analysis of TEs in the single-cell RNA-seq data. 
A.B. and J.R. provided the Mavs−/− and Sting−/− bones. R.R. and M.G.F. provided useful 
advice and performed part of the TE analysis. A.M.-H. and S.M.-F. performed the cell 
cycle experiment on the LINE1 knockdown. T.C and E.T. wrote the manuscript with 
input from all of the authors. All of the authors have read and approved this manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Extended data is available for this paper at https://doi.org/10.1038/s41556-021-00707-9.
Supplementary information The online version contains supplementary material 
available at https://doi.org/10.1038/s41556-021-00707-9.
Correspondence and requests for materials should be addressed to E.T.
Peer review information Nature Cell Biology thanks the anonymous reviewers for their 
contribution to the peer review of this work.
Reprints and permissions information is available at www.nature.com/reprints.
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low quality and doublets that were filtered out computationally. High variability 
was observed in FLASH qPCR experiments regarding the TE copies that were 
bound. The experiments were not randomized. For serial CFU-C experiments, the 
investigators were blinded to group allocation during data collection and analysis. 
No other blinding was used as the nature of the experiments did not permit further 
blinding. Data are shown as mean ± s.d. or mean ± s.e.m. as indicated. Statistical 
analysis was performed using GraphPad Prism 8. Two-tailed t-tests were used to 
compare between groups and the statistical significance of the survival curve was 
estimated using the log-rank (Mantel–Cox) test.
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Extended Data Fig. 1 | HSC isolation after chemotherapy. a, Schematic of the experimental strategy followed for the RNA-seq and ATAC-seq 
experiments on WT HSCs. b, Gating strategies for sorting HSCs from the BM of D0 or 5-FU-injected (H2, H6, H16, D3, D10) mice (15 biologically 
independent samples- representative plots are shown). c, Comparison of our sorting strategy (LSK/SLAM) to the HSCs sorted using EPCR/SLAM 
(EPCR+CD48−CD1450+) markers. The EPCR/SLAM HSCs are then projected on the LSK/SLAM gating strategy (red color) and the percentage of EPCR/
SLAM HSCs that are included in the LSK/SLAM gate is indicated (2 biologically independent samples- representative plots are shown). d, Comparison of 
the number of cells in the LSK/SLAM gate that are not EPCR/SLAM at D0 and H16 (2 biologically independent samples- representative plots are shown). 
e, Gene ontology analysis of the genes upregulated at H2, H16 and D10 after 5-FU injection compared to D0 in WT HSCs. X-axis depicts -logP. f, Venn 
diagrams depicting the overlap of differentially expressed genes (DEGs) in WT HSCs with genes assigned to newly accessible regions-gained ATAC peaks 
at the indicated time points compared to D0 (-100/+25 kb from TSS, p-values represent hypergeometric test). g, Gene ontology analysis of deregulated 
genes that also exhibit changes in chromatin accessibility at the indicated time points. X-axis depicts -logP.
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Extended Data Fig. 2 | See next page for caption.
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Extended Data Fig. 2 | TEs bind to MDA5 upon stress in human and mouse cells. a, Bar graphs depicting the mean counts of LINE, SINE, LTR and DNA 
transposon (DNA) RNA (fold change >1.5 and p-value < 0.05) bound to MDA5 or GFP after irradiation or decitabine treatment (sense DNA strand-upper 
panel, antisense DNA strand-lower panel) (n = 2 biologically independent population samples, 2 independent experiments). b, Bar graphs depicting the 
mean counts of LINE, SINE, LTR and DNA transposon (DNA) RNA (fold change >1.5 and p-value < 0.05) bound to MDA5 after irradiation or decitabine 
treatment or to MDA5 without treatment (sense DNA strand-upper panel, antisense DNA strand-lower panel) (n = 2 biologically independent population 
samples, 2 independent experiments). c, Representative track that shows binding of L1M4c to GFP after irradiation or decitabine treatment and to MDA5 
without treatment or after irradiation or decitabine treatment. Y-axis represents RPKM. Crosslinking events are also shown. d-e qPCR experiments 
after FLASH depicting binding of TEs to GFP or MDA5 after irradiation or decitabine treatment (d) or to MDA5 without treatment or after irradiation or 
decitabine treatment (e) (n = 2 biologically independent samples and experiments). f, qPCR experiment after FLASH from mouse OP9 cells depicting 
binding of LINE1 elements to GFP or MDA5 without treatment or after irradiation (n = 2 biologically independent samples and experiments).
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Extended Data Fig. 3 | See next page for caption.
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Extended Data Fig. 3 | MDA5 is required for HSC activation. a, Representative profile comparing Sca-1 expression on the lineage negative fraction of the 
BM of WT or Mda5-/- mice (3 biologically independent samples, one representative plot is shown). b, Side population (SP) frequency in the BM of WT 
or Mda5-/- mice (n = 4 biologically independent samples, mean+s.d, two-tailed t-test, n.s. non-significant). c, Homing assay: percentage of donor derived 
LSK cells in the BM of WT recipients (n = 3 biologically independent samples) 16hrs after injection of BM cells from WT or Mda5-/- mice (mean + s.d., 
two-tailed t-test, n.s. non-significant). d, Percentage of donor derived myeloid, B or T lymphoid cells in the peripheral blood of recipients injected with BM 
cells isolated from WT (n = 30 biologically independent samples) or Mda5-/- mice (n = 27 biologically independent samples). Time (weeks) denotes the 
time after intravenous injection (mean ± s.d, two-tailed t-test, n.s. non-significant). e, Cell cycle analysis of HSCs and MPPs as indicated (n = 7 biologically 
independent samples, mean-s.d., two-tailed t-test). f, Bar graphs depicting the frequency of cells with detectable mitochondrial mass measured by 
MitoTracker Green (left panel) and reactive oxygen species (ROS) production (right panel) at D3 after 5-FU injection (n = 2 biologically independent 
samples and experiments). g, Images of γH2AX foci positive HSCs from WT or Mda5-/- mice (left) and quantification of γH2AX foci per nuclei at D3 
after 5-FU injection (mean ± s.e.m., two-tailed t-test, n = 64-WT and 56-Mda5-/- cells examined in 2 independent experiments). h, Dot plot representing 
quantification of γH2AX foci per WT or Mda5-/- HSCs nuclei quantified with Imaris software 9.2 after culturing cells for 48 h (n = 121-WT and n = 127-
Mda5-/- cells examined in 2 independent experiments, mean±s.e.m., two-tailed t-test, *P = 0.036). i, Cell cycle analysis of WT HSCs after cytarabine 
treatment (n = 4 biologically independent samples and experiments, mean-s.d., two-tailed t-test). j, Cell cycle analysis of WT and Mda5-/- HSCs after 
cyclophosphamide (n = 7 biologically independent samples and experiments, mean-s.d., two-tailed t-test).
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Extended Data Fig. 4 | See next page for caption.
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Extended Data Fig. 4 | 5-Fu treatment in Mda5-/- HSCs. a, Bar graphs depicting the number of differentially expressed genes at different time points 
after 5-FU treatment in Mda5-/-HSCs (H2, H16: n = 2 and D0, D3: n = 3 biologically independent samples, fold change cut-off 1.5, Padj < 0.05). b, Gene 
ontology of upregulated genes at indicated time points versus D0. c, t-SNE representation of Mda5-/- HSCs at D0 (red) and H16 (dark red) (left) (number 
of sequenced cells in parentheses). t-SNE representation of DEGs between H16 and D0 in Mda5-/- HSCs. Color scale: log2 of normalized transcript counts 
(right) d, Violin plots depicting log2 fold change expression at D0 or H16 in Mda5-/- HSCs. Box: interquartile range, whiskers: minimum and maximum 
values, horizontal line: median. Each dot represents a single cell; the plot shape declares probability density (n = 552 Mda5-/- D0 and n = 1096 H16 
cells, one independent experiment per time point, Padj < 0.05). e, Gene set enrichment analysis in Mda5-/- HSCs from c between D0 and H16 f, t-SNE 
representation of WT (blue) and Mda5-/- HSCs (red) at D0 (number of sequenced cells in parentheses). g, t-SNE representation of DEGs between H16 and 
D0 in WT and Mda5-/- HSCs. Color scale: log2 of normalized transcript counts. h, Gene set enrichment analysis between WT and Mda5-/- HSCs at D0. i, 
t-SNE representation of WT (green) and Mda5-/- HSCs (red) at H16 (number of sequenced cells in parentheses). j, Violin plots depicting log2 expression 
of Cdk6 at H16 in WT and Mda5-/- HSCs. Box: interquartile range, whiskers: minimum and maximum values, horizontal line: median. Each dot represents 
a single cell; the plot shape declares probability density (n = 1087 WT H16 and n = 997 Mda5-/- H16 cells, one independent experiment per time point, 
Padj < 0.05). k, Venn diagrams depicting the overlap of differentially expressed genes (DEGs) with genes gaining accessibility (-100/+25 kb from TSS) 
(p-values: hypergeometric test). l, Table of upstream regulators for WT unique accessible regions assigned to proximal genes (+/-25kB) at H16.
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Extended Data Fig. 5 | 5-Fu treatment induces inflammation. a, Representative plot depicting phospho-IRF3 staining in WT and Mda5-/- HSCs gated 
in LSK cells or HSCs (left panels). Tables depicting the mean fluorescence intensity (MFI) of pIRF3 in WT and Mda5-/- HSCs at the indicated time points 
(right panels) (two-tailed t-test, P values are indicated below). b, Measurement of secreted cytokines in WT (left) or Mda5-/- (right) BM at D0 and D3 
(n = 7 D0 and n = 5 D3 for WT and n = 8 D0 and n = 5 D3 for Mda5-/- biologically independent samples, 2 independent experiments, two-tailed t-test, 
n.s: not significant, horizontal line: mean). c, Measurement of secreted cytokines in WT bone marrow at D0 (n = 4), H2 (n = 8), H6 (n = 6) and H16 
(n = 6) (left) or D0 (n = 4) and D10 (n = 6) (right) (all biologically independent samples, 2 independent experiments two-tailed t-test, n.s: not significant, 
horizontal line: mean).
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Extended Data Fig. 6 | See next page for caption.
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Extended Data Fig. 6 | TE expression affects HSC cell cycle. a, Bar chart depicting the median fluorescence intensity (MFI) of γH2AX signal of WT or 
Mda5-/- HSCs 24 h after poly(I:C) injection (n = 5 biologically independent samples, mean±s.d., two-tailed t-test). b, RT-qPCR analysis of WT HSCs at D0, 
H2 and H16 after 5-FU injection for Setdb1 (n = 4 biologically independent samples for D0 and H2, n = 3 for H16 biologically independent samples in two 
independent experiments). c, Cell cycle analysis of WT HSCs after transfection of control or Setdb1 siRNA (n = 8 biologically independent samples for 
control siRNA and n = 9 for si-Setdb1 in two independent experiments, two-tailed t-test, mean + /-s.d). d, qRT-PCR analysis of HSCs 20 h after transfection 
with empty vector (EV), or both strands of the indicated TE copies in WT or Mda5-/- HSCs (n = 2 biologically independent samples). e, Cell cycle analysis 
of WT HSCs transfected with empty vector (EV) or the vector expressing GFP (n = 2 for EV and n = 3 for GFP biologically independent samples, two-
tailed t-test, mean-s.d, n.s. non-significant). f, Measurement of secreted cytokines in supernatant of WT HSCs transfected as indicated (n = 8 biologically 
independent samples, 2 independent experiments, mean ± s.e.m, two-tailed t-test) g, qRT-PCR analysis of LSK cells 48 h or 72 h after knock-down of LINE1 
families (n = 2 biologically independent samples). h, Cell cycle analysis of WT HSCs 48 hours after culture in presence of the indicated concentration of 
TBK1 inhibitor (BX795) (n = 2 biologically independent samples).
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Extended Data Fig. 7 | Effect of the TE-MDA5-Inflammation axis on HSC activation. Schematic showing that chromatin rearrangement occurs after 
chemotherapy concomitant to activation of TEs that are transcribed (H6-H16). TE transcripts bind to MDA5 to induce phosphorylation and thus activation 
of IRF3 and translocation of p65 to the nucleus (H16). This leads to activation of interferon responsive genes (H16) and secretion of proinflammatory 
cytokines (D3) followed by HSC cycling. Created with BioRender.com.
NATuRE CELL BIOLOGy | www.nature.com/naturecellbiology
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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection Sequencer: Illumina Illumina Hiseq3000, NovaSeq6000, NextSeq 500 
Sequencing data demultiplexing: Illumina bcl2fastq 2.17.1  
Flow cytometry: Fortessa FACS analyser, FACS ARIAIII or FACS ARIAFusion (BD Biosciences) 
Imaging: LSM 880 (Zeiss), Axio Vert.A1, Zeiss 
Cell counting: Casy Cell counter(OLS/Cytena).  
qPCR: ABI StepOnePlus thermal cycler (Applied Biosystems), StepOnePlus Real-Time PCR machine (Applied Biosystems).   
Data analysis RNA-ATAC-FLASH 
 
Trimmomatic (version 0.36) 
STAR aligner (version -2.5.3a) 
Samtools (version 0.1.19) 
HTseq count (version 0.5.4p3.) 
DESeq R package 
gplots package (https://cran.r-project.org/package=gplots) 
R package Shiny (https://shiny.rstudio.com/) 
TEtranscript (Version 2.0.3) 
RepeatMasker (http://www.repeatmasker.org) 
Pretty Heatmaps. R package version 0.7.7. http://CRAN.R-project.org/package=pheatmap 
MACS2 (version 2.1.0)  
TrimGalore (Version0.4.3 and 0.4.4) 
Bowtie2 (version 2.1.0) 
BEDTools 
DeepTools 
Wellington pyDNase package (version 0.2.4) 
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dnase_average_profile.py of the Wellington pyDNase package 
wellington_score_heatmap.py 
Bowtie2 algorithm (version 2.1.0) 
HOMER software59 
Metascape (metascape.org) 
bwa (version 0.6.2-r126)  
umitools 0.5.1  
featureCounts from the subread-1.5.3 package  
Samtools 1.6.0.  
VarID algorithm 
RaceID3 algorithm   
GSEA was performed using gsePathway function of ReactomePA, an R/Bioconductor package 
Flexbar (version 3.3) 
UMITools (Version 0.5.1) 
 
Flow cytometry: FlowJo 10.6.1. 
Imaging: Imaris software 9.2 
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
DATA AVAILABILITY 
Sequencing data that support the findings of this study have been deposited in the Short Read Archive SRA under accession codes PRJNA532318 (FLASH data), 
PRJNA717283 (RNA and ATAC-seq data) and PRJNA730379 (SETDB1 RNA-seq data). Single cell RNA-sequencing data have been deposited in the gene expression 




All codes used in this manuscript are available from the corresponding author upon reasonable request. 
 
Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size The sample size was determined empirically according to the nature of the experiments. Animal experiments had increased sample size in 
comparison to cell based experiments.
Data exclusions One transplantation experiment was excluded due to very low animal engraftment.  In the single-cell RNA-seq experiments the exclusion 
criteria were: low quality and doublets that were filtered out computationally 
Replication The number of replicates and independent experiments is indicated in the figure legends.  Besides the one transplantation experiment 
replication attempts were successful. High variability was observed in FLASH qPCR experiments regarding the TE copies that were bound. 
Randomization The experiments were not randomized. Age-matched male and female littermates were used according to obtained genotype. 
Blinding For serial CFU-C experiments the investigators were blinded to group allocation during data collection and analysis. No other blinding was 
used since the nature of the experiments did not permit further blinding.
Reporting for specific materials, systems and methods
3





We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems













Antibodies used All antibodies were purchased from Biolegend and used in 1:400 dilution unless indicated otherwise. CD45.1/Ly5.1 (APC-Cy7, 
clone A20), CD45.2/Ly5.2 (Alexa Fluor 700, clone 104), CD3e (FITC, clone 145-2C11), CD11b/Mac-1 (1:1600, FITC or PerCP-Cy5.5, 
clone M1/70), Ly6C/Ly6G (1:1600, FITC or PerCP-Cy5.5, RB6-8C5), CD45R/B220 (FITC or APC, Clone RA3-6B2), Ter119 (FITC, 
clone Ter-119), CD117/c-kit (Brilliant Violet 421[1:600]  or PE; Biolegend, or APC-H7, clone 2B8, [1:200] BD Bioscience,), Sca-1 
(Pe-Cy7, clone E13-161.7), CD48 (1:800, PerCP-Cy5.5, clone HM48-1), CD150 (1:600, PE-Dazzle or 1:600 Brilliant Violet 605, 
Clone TC15-12F12.2), CD135/Flk2 (1:200, PE, clone A2F10.1, BD Pharmingen), CD34 (1:30, Alexa Fluor 700 clone RAM34, 
eBioscience), Ki67 (1:200, Alexa Fluor 647, clone 11F6), CD201 (1:200, EPCR, PE anti-mouse clone RCR16), p-IRF3 (1:25, S396, 
clone D601M, Rabbit mAb 29047, Cell Signaling), goat anti rabbit secondary antibodies (1:500, Alexa Fluor 647, A21245, 
Invitrogen), γH2AX antibody (1:100, Alexa Fluor 647 (Ser139), clone 2F3), p65 (1:100, Alexa Fluor 488, p65, Santa Cruz 
Biotechnologies). For the LINE1 knockdown experiments: Sca-1 (1:200, PerCPCy5.5 122523, E13-161.7clone, Biolegend), c-Kit 
(1:200, APCe780, 47-1171-82, clone 2B8, eBioscience), CD48-Alexa Fluor700 (1:200, 56-0481-82, clone HM48-1, eBioscience) 
and CD150 (1:200, PE-Cy7, 115913, clone TC15-12F12.2, Biolegend).
Validation Validation by manufacturer.APC-Cy7 anti-CD45.1/Ly5.1, Alexa Fluor 700 anti-CD45.2/Ly5.2, FITC anti-CD3e, APC or FITC anti-
CD45R/B220, Pe-Cy7 anti-Sca-1, PerCP-Cy5.5 or AF-700 anti-CD48, BV-605 or PE-Cy7 or PE-Dazzle anti-CD150, PerCPCy5.5 anti 
Sca1, APCe780 anti c-kit, CD48-Alexa Fluor700,  AF-647 anti-Ki67, – flow cytometry on mouse splenocytes 
FITC or PerCP-Cy5.5 anti-CD11b/Mac-1, FITC or PerCP-Cy5.5 anti-Ly6C/Ly6G, FITC anti-Ter119, BV-421 or PE or APC-H7 or 
APCe780 anti-CD117/c-kit, AF-700 anti-CD34, – flow cytometry on mouse bone marrow cells 
PE anti-CD135/Flk2 – flow cytometry on mouse bone marrow leukocytes 
PE anti-CD201/EPCR – flow cytometry on HUVEC cells 
AF-647 anti-γH2AX – imaging on Nocodazole-treated Hela cells 
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals  Mda5-/- mice (B6.Cg-Ifih1tm1.1Cln/J)44 were purchased from the Jackson Laboratory and backcrossed 10 times into C57BL/6J 
WT mice (CD45.2+/Ly5.2). Sting-/- mice bones (B6(Cg)-Sting1tm1.2Camb/J)55, and Mavs-/- mice bones (Mavstm1Tsc)56 and 
their respective controls, were a kind gift from Jan Rehwinkel. All animals were were maintained in the animal facility of the Max 
Planck Institute of Immunobiology and Epigenetics under specific pathogen free conditions in individually ventilated cages  with 
a light-dark cycle of 12 hours at 20-24oC with 45-65% humidity. For all genotypes, 6- to 12-week-old age and gender-matched 
female or male mice were used in the experiments.
Wild animals This study did not involved wild animals
Field-collected samples This study did not involved field-collected samples.
Ethics oversight All mouse experiments were carried out in accordance to the guidelines of the Federation of European Laboratory Animal 
Science Association and following legal approval of the Regierungspräsidium Freiburg (35/9185.81/G-15/100, 35-9185.81/
G-18/41, 35-9185.81/G-18/127, 35-9185.81/G-20/127). 
Note that full information on the approval of the study protocol must also be provided in the manuscript.
4








The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Bone marrow from tibiae, femurs and hip bones were crushed in staining buffer (PBS supplemented with 2 %FBS and 1 mM 
EDTA) using a mortar and pestle and filtered through a 70-μm cell strainer (Flacon, 352350) to isolate the BM cells. Red cells 
were lysed in an Ammonium-Chloride-Potassium Buffer (ACK-Lysis Buffer, NH4Cl 150 mM, KHCO3 10 mM, EDTA 0.1 mM) for 5 
min at room temperature. Cells were then washed with staining buffer.  
For the LINE1 knockdown experiment BM was extracted from femur, pelvic bone, tibias and spine via crushing. Further 
preparation is described in the Methods section.
Instrument Data were either acquired on a Fortessa FACS analyser (Becton Dickinson) or sorted using a FACS ARIA III or FACS ARIA Fusion 
(Becton Dickinson).
Software FlowJo 10.6.1
Cell population abundance Purity check was perfomed on a more abundant population (LSK CD48+CD150+) as the number of HSCs after sorting was on 
average 3,000-5,000 per animals.
Gating strategy Unstained population and single staining controls were used to to both gating strategy and correct spectral overlaps. The gating 
strategy can be found in Extended Data Fig. 1 and the markers used for each population can be found in the section "Sorting 
strategy" in the methods section.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
